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Abstract
Mitochondria are essential to the process of cell respiration and
steroidogenesis. Both of these processes impact the viability of the corpus
luteum, which is required to maintain early pregnancy. In cattle and other
species, progesterone supports gestation, regulates embryogenesis and works in
concert with estrogen to maintain the reproductive tract. Many investigators have
sought to understand the processes that control regression of the corpus luteum.
Two prostaglandins, PGF2! and PGE2, have been implicated in the functioning
of this transient gland. It is accepted by most researchers that the primary
luteolysin responsible for functional and structural demise of the corpus luteum is
PGF2!. However, there is ambiguity between reported effects of PGF2! and
PGE2 on whole cells and on animals in vivo. Therefore, the specific effects of
these prostaglandins on oxygen consumption and progesterone secretion in
mitochondria isolated from bovine corpora lutea are the focus of this dissertation.
A decrease in oxygen consumption and a concomitant decrease in ATP may
contribute to luteolysis. These in vitro studies using isolated mitochondria may
help to resolve these questions. The first objective was to determine the
influence of PGF2! and PGE2 on the oxygen consumption of mitochondria
isolated from bovine corpora lutea. The second objective was to determine the
effect of both of these prostaglandins on mitochondrial progesterone production.
This is the first time that the direct effects of PGF2! on mitochondrial cellular
respiration and steroidogenesis have been studied in the corpora lutea of any
species. These results will expand information in the area of ovarian physiology
and may clarify the roles of PGF2! and PGE2 in corpus luteum function.
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Chapter I. Introduction
Most of our knowledge of reproductive physiology has transpired during
the past 85 years.

Advances such as artificial insemination, estrous

synchronization, embryo transfer, in-vitro fertilization, and contraception, to
mention just a few, have all emerged in the past few decades (Alexander et al.,
2010; Abeydeera, 2002). Now that we have achieved some control over
reproduction, it has become conceivable to consider optimum population size,
whether the reference point is the number of cattle or the number of humans
(Sande et al., 2008; Myrsky et al., 2009). A balance needs to be achieved to
avoid degradation of the quality of life and the erosion of resources.
In 1855 a rapid increase in knowledge led to the beginning of what is
called modern reproductive physiology. It was recognized that the gonads
produce steroid hormones that affect reproductive tissues and that the anterior
pituitary controls the function of the gonads. In the 1940s and 50s the
understanding of the physiology of sperm led to successful artificial insemination
of many species. In the 1960s it became apparent that PGF2 alpha regulates
the length of the estrous cycle in most mammals (Mellin and Busch, 1976:
McCracken et al., 1999). Now the cycle could be manipulated to control the
timing of ovulation. In 1960, the development of radioimmunoassay made
possible the precise measurement of hormones (Yalow and Berson, 1960; see
also Yalow, 1978; 1995). The discovery that ovarian stem cells can replenish
oocytes in postnatal mammalian females is a revolutionary breakthrough.

It

overturns the belief that oogenesis does not occur in postnatal life. Stem cells in
the ovary can supply functional follicles in post-natal ovaries. The evidence for
!
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neo-oogenesis under normal conditions remains controversial, however.
Manipulation of stem cells can have tremendous applications in animal
production (Mooyotto S, 2011).

Despite the multitude of modern advances,

much remains to be elucidated. The result of our investigations into the effect of
prostaglandins on respiration and steroidogenesis will complement and extend
previously published data on ovarian physiology.
Primary Reproductive Hormones in the Female
Quiescent neurons located in the hypothalamus become active at puberty
(Plant and Barker-Gibb, 2004).

At the initiation of puberty, gonadotropin

releasing hormone (GnRH) is produced by neurons in the surge center and tonic
center of the hypothalamus. Communication between the hypothalamus and the
anterior pituitary occurs via a portal system that consists of a capillary bed. This
allows minute quantities of releasing hormone to act directly on the cells of the
anterior pituitary before dilution by the systemic circulation (Charlton, 2008). The
primary hormones secreted by the anterior pituitary are follicle stimulating
hormone (FSH) and luteinizing hormone (LH).

Luteinizing hormone targets

receptors in the theca and follicle stimulating hormone targets receptors in the
granulosa cells. After an increase in the secretion of estradiol by the granulosa
cells, luteinizing hormone peaks, culminating in ovulation and stimulation of the
corpus luteum to produce progesterone. Progesterone and estrogen have
important roles in regulating various physiological functions related to growth,
development, and reproduction in domestic animals. Recent research suggests
that these two hormones can alter target cell responses nongenomically via a
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membrane receptor (Blesson et al., 2012).

Estrogen can suppress LH and

progesterone, also acting via a membrane receptor and has been shown to
inhibit binding of oxytocin to its receptors in vitro (Stormshak and Bishop, 2008).
As the name implies, follicle stimulating hormone causes the growth of
follicles in the ovary. The neurohormone, oxytocin, is produced in the
hypothalamus and released from the posterior pituitary, exerting its effects on the
ovary, uterus, and mammary gland.

Along with estrogen, it is involved in

inducing the endometrial synthesis of PGF2!, causing regression of the corpus
luteum (Flint et al., 1986; McCracken et al., 1999).
Dissertation Chapters
Chapter 1, Introduction, lists the primary topics discussed in succeeding
chapters and includes a review of the literature. The morphology of mitochondria,
their

involvement

in

corpus

luteum

function,

their

role

in

apoptosis,

steroidogenesis and respiration is discussed in Chapter 2. In Chapter 3 the
biosynthesis of prostaglandins is examined, as well as their interaction with nitric
oxide, endothelin -1 (ET-1), and oxytocin in contributing to luteolysis . In addition,
in Chapter 3 the effect of PGF2! and PGE2 is emphasized, since our
investigation is concerned with the influence of these two prostaglandins on
progesterone synthesis and their effect on luteal cell respiration. Cholesterol and
its conversion to steroid hormones is discussed in Chapter 4, which includes
various enzymes involved in steroidogenesis and the importance of steroidogenic
acute regulatory protein (StAR) and translocator protein (TSPO) in the entrance
of cholesterol into the mitochondria. Chapter 5, focuses on respiration and the
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locus where known inhibitors of the process act. Chapter 6 contains statements
of our hypothesis and objectives.

Materials, methods, and statistical analysis

are the subject of Chapter 7. Chapter 8 summarizes our results and conclusions,
including the effects of PGF2! and PGE2 on luteolysis.
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Review of the Literature
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Chapter II. Mitochondria
Historical Review
The earliest records of structures which probably represent mitochondria
are found in the 1840s (Henle, 1841; Retzius, 1890). This is only a few years
after the cell nucleus was discovered. Altmann, in 1890 was the first to realize
that these “bioblasts” could be organisms living inside cells that are capable of
performing important functions.

The name “mitochondrion” was first used in

1898 by Benda and originates from the Greek word for thread, “mitos” and
granule, “chondros”.
In 1925, Keilin discovered the cytochromes, leading to the conclusion that
the respiratory chain was a sequence of enzymes with the dehydrogenases on
one end and an iron-containing respiratory enzyme on the other end (Keilin,
1925). Several experiments in the late 1930s uncovered the reaction pathways
of aerobic respiration. In 1937 Sir Hans Krebs (Krebs and Johnson, 1937)
described the biochemistry of the citric acid cycle. In 1939 Belitser and
Tsybakova found that two molecules of ATP are formed per atom of oxygen
consumed.

These experiments led to the speculation that phosphorylation

probably occurs as part of the respiratory chain. In the late 1940s, Friedkin and
Lehninger verified the supposition that the respiratory chain and phosphorylation
are linked. It is significant that all these important developments occurred before
it was known that these intracellular “particles” were mitochondria (James and
Arney, 1939). Detailed information on mitochondrial ultrastructure awaited the
development of thin-sectioning techniques in the 1950s. In 1952, Palade
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discovered that the mitochondrion is surrounded by a membrane which is folded
into “cristae”. The micrographs of Sjostrand (Sjostrand and Rhodin, 1953)
revealed a double membrane surrounding the mitochondrion.
Research of the past thirty years has strengthened the hypothesis that
mitochondria are symbionts of a primitive eukaryote (Margulis, 1981). A more
recent theory called the serial endosymbiotic theory suggests that a
protoeukaryotic cell lacking mitochondria evolved first and was able to
incorporate a proteobacterium by endocytosis.

Transfer of genes from the

bacterium to the nucleus of the protoeukaryotic cell resulted in the distribution of
genes, which are currently seen in the two genomes (Gray, 1993; Gray et al.,
1999).
Many mitochondrial DNAs (mtDNA) from different organisms have now
been completely sequenced (Scheffler, 2000). Most genomes encode proteins
of Complexes I, III, IV, and Complex V of the electron transport chain.
Evolutionary studies are now concentrating on the nucleotide sequences of
specific genes with the intention of further elucidating the evolutionary origins of
the mitochondria (Scheffler, 2000).

Absolute proof to determine the

monophyletic versus multiphyletic origins of the mitochondria or to ascertain their
relationship to present day bacteria may not be possible, because we lack a
representative of their common ancestral form (Scheffler, 2000).
Morphology
The basic morphology of mitochondria as a matrix enclosed by an inner
and outer membrane separated by an intermembrane space was revealed when
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the earliest electron microscope was developed. Transmission electron
microscopy permitted more detailed views, showing that the inner membrane is
folded into what are now called “cristae” (Karbowski and Melino, 2003).
Decades after this early view was accepted, a revisionist view of the
mitochondrial membrane is currently being explored (Mannella, 2000; Perkins
and Frey, 2000). Electron microscopic tomography, which is analogous to
“computerized axial tomography” (CAT scan), has permitted the reconstruction of
Leydig cell mitochondria in three dimensions (Prince and Buttle, 2004). The
unusual morphology of mitochondria in Leydig cells may be typical of
mitochondria in other steroidal tissue (Prince, 1999). In human Leydig cells a
form of the cristae termed the lamellar association (LA) is apparent. The cristae
are arranged in apposed layers within the inner mitochondrial membrane, each
layer separated by a 4 nm gap.

The LA appears to be unique to steroid-

producing cells. It is surmised that the LA are present in a region of the cristae
which is not involved in ATP production, since the dimensions do not allow for
complexes on the matrix side of the cristae.

One of the subunits of ATP

synthetase is too large to be accommodated in the membrane (Prince, 2000).
In human Leydig cells, the surface area of the inner membrane is divided
into two domains. One domain adheres closely to the outer membrane, making
contacts with the outer membrane in several locations. This domain has been
termed the “inner boundary domain”. The second domain of the inner membrane
forms the cristae, which are now interpreted to form lamellar structures, which
connect to the first domain of the inner membrane by tubular structures named
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“crista junctions” (Perkins et al., 1997). In many respects, the structure of the
cristae is similar to previous studies of nonsteroid-producing cells. Unique to
steroid-producing mitochondria, however, is a type of crista in which the lamellae
are closely applied to each other. These interconnections form an extensive
internal membrane system. This system has an extensive surface area with few
openings to the inner boundary membrane. The significance of this form of the
cristae is unknown (Prince and Buttle, 2004).
These investigations into the morphology of the cristae give rise to several
questions. Are proteins limited in their distribution between the two domains?
Does the membrane potential vary from one region of the inner membrane to
another? What maintains these two domains of the inner membrane (Scheffler,
2000)? A final answer remains elusive (Ernster and Schatz, 1981).
Variations can be found in the number, size, and shape of mitochondria
(Racker, 1970; Tandler and Hoppel, 1972; Novikoff, 1961). Examples of variation
can be observed in insect flight muscles, where mitochondria are arranged in a
slab-like orientation (Edwards and Ruska, 1955). In the proximal kidney tubule
cells and in the flagella of sperm, there is a single, large mitochondrion at the
base of the cell. Intracellular distribution of mitochondria depends upon several
circumstances, including cell shape, organization of the cytoskeleton, and energy
demands of the cell (Sjostrand and Rhodin, 1953). The morphology of
mitochondria in human oocytes varies from oogenesis through embryonic stages.
The mitochondria are initially rounded, becoming fewer in number and elongate
after implantation (Nicholls and Budd, 2000).
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Understanding alterations in mitochondria morphology can explain many
disease conditions. Abnormal mitochondria cause neuronal synaptic loss and
cell death in Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease
(Seo et al., 2010).
Movement Capability
Mitochondria are capable of movement. This is especially apparent during
mitosis. However, the significance of these movements is unknown (Frederic
and Chevremont, 1952). In 2006, cultured mammalian cells were tagged with
green fluorescent dye to investigate mitochondrial movement. Because of the
diverse roles of mitochondria, their distribution within the cell is of great
importance. Lysophosphatic acid, acting via GTPase RhoA, was found to inhibit
fast movement. Investigators concluded that mitochondrial movement is
controlled by GTPase RhoA and this control is mediated by formins (Minin et al.,
2006).
Interactions of proteins on the outer membrane and components of the
cytoskeleton, including actin filaments, microtubules, and intermediate filaments
are involved in movement of the mitochondria (Scheffler, 1999). An obvious
problem ensues regarding the equal distribution of mitochondria during cell
division. Outer membrane structures identified in yeast suggest that there is
interaction between cytoskeletal structures and mitochondria in diverse
cytoskeletal structures in different organisms (Yaffe, 1999).
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Replication – Fission and Fusion
The observation has been made that mitochondria undergo both fission
and fusion (Bereiter-Hahn and Voth, 1994). Images of mitochondria that appear
to be dividing show a septum that can be seen by electron microscopy.
Components of the outer membrane in yeast lend credence to the idea that
mitochondria can interact with cytoskeletal structures in different organisms
(Yaffe, 1999). Evidence from yeast and fungi support the idea that mitochondria
form a reticulum or network that is constantly undergoing fissions and fusions. It
is known that proteins are continuously mixed and exchanged between
mitochondria or within the reticulum (Suelmann and Fischer, 2000).

Other

evidence supports the hypothesis that mitochondria in mammalian cells may
form an interconnected network that may be involved in the delivery of energy or
channel calcium between areas of the cell (Frey and Mannella, 2000).
Mitochondria provide a buffering system, which controls the amount of calcium in
the cytosol versus the amount required within the mitochondria for the action of
dehydrogenases in Krebs cycle (Hansford, 1994), a system which may be
dependent upon a network of microtubules.
In eukaryotes, mitochondria may replicate their DNA and undergo fission
in response to energy needs of the cell.

When energy needs are low,

mitochondria are destroyed, but if ATP is needed, mitochondria increase in
number by fission. A spiral of dynamin forms a helical tube around the organelle,
constricts when GTP is added, pinching the mitochondrion into two halves
(Mears et al., 2011). Two mitochondria can also merge into one, a process called
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fusion. There appears to be a balance between fission and fusion, but how the
balance is maintained is unknown.
Mitochondria are apparently randomly distributed to daughter cells during
cytokinesis. A daughter cell that fails to receive mitochondria will not survive,
since mitochondria cannot be synthesized de novo. Their number may be
increased by fission, but since their genome is uniparental, they will lack
variation.

Even if recombination occurs, it will not result in greater genetic

diversity, since an individual’s mitochondrial genes are inherited from the female
parent. Although mitochondria in the sperm enter the egg, they are destroyed by
ubiquitin in the embryo (Sutovsky et al., 1999). The study of maternal inheritance
has been useful for divulging the evolutionary history of populations (Lunt et al.,
1997).
Mitochondria in the Corpus Luteum
Mitochondria are essential for luteal cell function in three ways. They
generate most of the ATP required by the cell for energy. Secondly, they are the
site of the initial stage of steroidogenesis during which pregnenolone is
synthesized from cholesterol and subsequently metabolized to produce
progesterone. Thirdly, they release pro-apoptotic proteins, e.g. cytochrome c,
that activates the caspase cascade which triggers apoptosis and programmed
cell death (Niswender, 2002).
All three of these mitochondrial roles interact during the life and demise of
the corpus luteum. After ovulation the theca interna and granulosa cells of the
follicle become transformed into luteal cells. This structural and functional
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remodeling is partially dependent upon the apoptotic capability of the
mitochondria. The cells of the corpus luteum synthesize steroids, require ATP,
and regress to allow the initiation of the next estrous cycle. Mitochondria within
the corpus luteum initiate steroidogenesis via the production of pregnenolone, a
portion of which is subsequently metabolized to progesterone, the primary
hormone produced by the corpus luteum and which is essential for the
maintenance of pregnancy (Stocco and Sodeman, 1991). All these cellular
transformative events require energy.

The energy is supplied by oxidative

phosphorylation within the mitochondria (Niswender and Nett, 1994). It is logical
to study the mitochondria and the corpus luteum in concert, since their roles are
intertwined.
Involvement of Mitochondria in Cell Respiration
Cells store and use the energy in the bonds of ATP, which is synthesized
primarily in the mitochondria. The first stage of cell respiration, called glycolysis,
is anaerobic and occurs in the cytosol. The product of this first stage, pyruvate,
which enters the mitochondrial matrix, is oxidized to acetyl-CoA, which enters the
second stage, the “citric acid cycle” or “Krebs cycle”. The two products
synthesized in the second stage, (NADH and FADH2) donate electrons and
hydrogen atoms which provide energy for the generation of ATP which occurs in
the third stage (Nelson and Cox, 2005).
The third and last stage of aerobic respiration, oxidative phosphorylation
(electron transport chain), is pertinent to our investigation since it culminates in
the production of the energy-rich compound, ATP. It occurs on the inner
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membrane of the mitochondria, where enzymes are lined up in an efficient
sequence. The first protein in the transport chain to receive the electrons from
NADH (which was synthesized in the Krebs cycle) is an enzyme embedded in
the membrane, NADH dehydrogenase located in Complex I. A mobile carrier
called ubiquinone passes the electrons from Complex I to Complex II. Succinate
enters the transport chain at Complex II and also donates electrons to
ubiquinone. Complex III, also called the Cytochrome bc1 Complex, passes the
electrons to cytochrome c. From cytochrome c, the electrons are passed to
Complex IV (cytochome c oxidase). Each passage of electrons is accompanied
by the expulsion of a proton into the space between the inner and outer
membrane of the mitochondrion. Hydrogen protons are combined with oxygen at
Complex IV, producing water (Butterworth PJ, 2005).
Protons that have accumulated in the intermembrane space enter the ATP
synthase complex, sometimes designated Complex V. The parts of this complex
are arranged in such a way that it resembles a rotary engine. As hydrogen
protons enter this structure from an area of high concentration to an area of low
concentration, the ATP rotator turns, producing the energy for the synthesis of
ATP from ADP and phosphate (Nelson and Cox, 2005). ATP is available to
provide energy for all the processes required to maintain life. Thus growth and
function of the corpus luteum are dependent upon the respiratory role of the
mitochondria
State IV oxygen consumption rate (OCR) of the mitochondria is defined
as in vitro oxygen consumption by isolated mitochondria in a substrate
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(frequently succinate) in the absence of ADP or any inhibitors. Determination of
the OCR provided verification that our mitochondria were alive and able to utilize
succinate as a substrate. In addition, determination of the OCR allows us to
ascertain what effect the addition of PGF2! and PGE2 would have on oxygen
consumption prior to ATP production.
Involvement of Mitochondria in Steroidogensis
Steroid hormones are made from cholesterol.

The conversion of

cholesterol to pregnenolone occurs inside the mitochondria where the cholesterol
side-chain-cleavage enzyme, (P450scc), resides on the matrix side of the inner
mitochondrial membrane (Bose et al., 2002; Stocco, 2001). Thus, P450scc and
enzymes of the electron transport chain both occupy the inner mitochondrial
membrane.

It has been shown that P450scc can function only in the

mitochondria (Black et al., 1994). Once thought to be the rate-limiting step in
biosynthesis of steroids, P450scc enzymatic activity is now known to rely upon
the steroidogenic acute regulatory protein (StAR), which has been localized to
the outer mitochondrial membrane. It is StAR which makes cholesterol available
to the P450scc enzyme (Stocco, 2001; Strauss et al., 1999). A partner in the
transport of cholesterol is translocator protein (TSPO), which binds to StAR and
assists in the movement of cholesterol through the outer mitochondrial
membrane.
The first two enzymes in the steroidogenic pathway are P450scc and
3 " hydroxysteroid dehydrogenase (3 " HSD). The latter enzyme converts
pregnenolone to progesterone and is found primarily in the cytosol. However,
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recently it has been located within the mitochondria, inferring that some
progesterone may be synthesized within the mitochondria as well (Stocco, 2000;
Chapman et al., 2005). Earlier evidence that HSD is located within mitochondrial
fractions of ovarian tissue was reported by Jackanicz and Armstrong, 1968;
Sulimovici and Boyd, 1969; and Flint and Armstrong, 1971). Data from these
investigations confirm that conversion of cholesterol to progesterone can occur
within the mitochondria of rat and bovine corpora lutea and perhaps within
mitochondria of other species as well. Further metabolism of progesterone
occurs in the cytosol of tissue that produces steroids further down the
steroidogenic pathway, such as glucocorticoids, estrogen and testosterone (Li et
al., 1997).
Several

comparisons

can

be

made

between

respiration

and

steroidogenesis. First of all, both processes occur on the inner mitochondrial
membrane. The manner in which both processes are accommodated on the
inner membrane is a matter of current speculation.
The path of electron flow in steroidogenesis involves NADPH and FADH2
(nicotinamide nucleotides or flavin nucleotides). A series of

oxidation/reduction

reactions is initiated. The path of electron flow in steroidogenesis involves a
compound similar to NADH, NADPH and the same steroidogenic electron
acceptor, FADH2.

The respiratory electron acceptors carry electrons from

catabolic reactions to the electron transport chain and the steroidogenic electron
acceptors carry electrons to anabolic reactions. Cells maintain separate groups
of NADH (respiratory electron acceptor) and NADPH (steroidogenic electron
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acceptor) and these two types of acceptors differ in their capability to perform
reduction and oxidation reactions.

NADH is found in mitochondria and

associated with catabolic reactions, e.g. oxygen consumption; whereas NADPH
is an enzyme complex found in the plasma membrane and associated with
anabolic reactions. Both NADH and NADPH decrease the permeability of the
outer mitochondrial membrane to ADP. Neither can cross the inner mitochondrial
membrane unassisted. However, the outer mitochondrial membrane is easily
crossed, since its pores are permeable to molecules smaller than 10 kDa. Both
of these electron acceptors are required for the processes of respiration and
steroidogenesis (Labedzka, 2006).
Involvement of Mitochondria in Apoptosis
All cells have a certain lifespan and eventually become candidates for
what is termed “programmed cell death” or apoptosis. Apoptotic factors affecting
the inner membrane necessarily will compromise cellular respiration and
steroidogenesis. Mitochondria play an important role in the process, which is
distinct from necrosis, allowing for the removal of old, damaged cells without the
destruction of neighboring tissues and permitting the conservation and reuse of
cell components such as amino acids and nucleotides. Apoptosis was described
by Kerr as long ago as 1972 (Kerr et al., 1972). Morphologic changes during
embryonic development, DNA damage, viral infections, accumulation of oxidative
stress (ROS), all require cell death and replacement. The process of functional
luteolysis requires uterine PGF2!, whereas structural luteolysis requires luteal
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PGF2! synthesis (apoptosis). A marker of apoptosis is activation of
endonucleases, which cleave DNA. The appearance of endonuclease activity in
the CL indicates that apoptosis occurs during luteal regression in cattle (Juengel
et al., 1993). There are two apoptotic pathways, but only the intrinsic pathway
involves the mitochondria, whereas the extrinsic pathway is initiated by
transmembrane death receptors such as Fas, located on the cell membrane.
The intrinsic pathway prevails if DNA damage or heat shock occurs. Ultimately,
cytochrome c is released by mitochondria and an amplification of the caspase
cascade is generated (Raff, 1998).
One early response to stress is an increase in permeability of the outer
mitochondrial membrane, allowing the release of cytochrome c into the cytosol
(Labedzka et al., 2006).

In the cytosol, cytochrome c interacts with inositol

triphosphate (IP3) on the ER, resulting in activation of calcium channels on the
membrane of the ER.

The sustained increase in calcium creates a positive

feedback mechanism whereby additional cytochrome c is released from the outer
mitochondrial membrane (Breckenridge et al., 2003).
Pro-apoptotic factors located on the outer membrane, are responsible for
the change in permeability, which permits the release of both cytochrome c and
the proapoptotic protein “second mitochondria-derived activator of caspase/direct
inhibitor of apoptosis-binding protein" (SMAC/DIABLO). If not subject to
inhibition, SMAC/DIABLO activates caspases (Chai et al., 2000).
Caspases are cysteine-aspartic acid proteases discovered in the 1990s
that are active in necrosis, apoptosis, and inflammation. Essentially, they cleave
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cell proteins, resulting in death of the cell. Caspases are active in both the
extrinsic and intrinsic pathways of apoptosis. Once released, cytochrome c binds
to the “apoptotic protease-activating factor-1”, (APAF-1), causing the formation of
an apoptosome composed of seven Apaf-1 and seven cytochrome c molecules.
It is the union of APAF-1 and cytochrome c that forms this large multi-protein
structure (Cereghetti et al., 2006).

Within the apoptosome, pro-caspase 9

activates an initiator caspase, turning on a caspase cascade.

Caspase 9

subsequently activates downstream effector caspases: 3, 6, and 7, thus
destroying the cells of the corpus luteum from within. Steroidogenetic activity of
the mitochondria is therefore compromised. As stated in the chapter on
respiration, cytochrome c carries electrons between Complex III and Complex IV.
There should be an awareness that cytochrome c has a completely separate role
as an instigator of apoptosis. Since it is a small, water-soluble enzyme, it is
mobile. When released into the cytoplasm from either the inner mitochondrial
membrane or the endoplasmic reticulum in response to pro-apoptotic stimuli, it is
involved in the initiation of apoptosis by binding to an apoptotic protease factor
(Skulachev, 1998). Thus, the processes of respiration and apoptosis both rely
upon cytochrome c. Cytochrome c may be involved in the apoptotic effects of
PGF2! as well.

Peterson (1988) found that PGE1, PGE2, and PGI2 all

decreased the synthesis of cytochrome c. However, PGF2! failed to decrease
the apoptotic effects of cytochrome c. Peterson’s study may therefore support
the luteotropic influence of PGE2 and the luteolytic influence of PGF2!, which
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has been well documented in numerous studies (Pratt et al., 1977; Fitz et al.,
1993).
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Chapter III. Prostaglandins
Historical Review
In1934, prostaglandin was discovered by von Euler of Stockholm during a
search for adrenaline in animal tissue. The term “prostaglandin” arises from its
discovery in seminal vesicles

from the prostate (Euler 1934, 1936).

Understanding the characteristics of prostaglandins was hindered by the lack of
methods to purify lipid-soluble substances. In 1959 two prostaglandins, PGE1
and PGF1!, were isolated by Bergstrom and Samuelsson, an achievement for
which Bergstrom, Samuelsson, and Vane received the Nobel Prize in 1982
(Bergstrom and Samuelsson, 1965).
The accepted nomenclature for the prostaglandins assigns letters to
denote functional groups in the cyclopentane ring.

The subscript numeral

indicates the number of double bonds, thus the degree of unsaturation. If the
hydroxyl group at position 9 in the cyclopentane ring is oriented below the plane
of the ring, the subscript ! is used; a hydroxyl group above the plane of the ring
is denoted by " (Zreik and Behrman, 2008; Craig, 1975).
Biosynthesis
Prostaglandins are all derived from arachidonic acid, a 20 carbon
polyunsaturated fatty acid containing a cyclopentane ring between C8 and C12
and two side chains (Sun et al., 1977). The corpus luteum contains abundant
arachidonic acid (Smith and Dewitt, 1996). Prostaglandins affect every organ in
the body. They regulate physiological processes such as pregnancy, ovulation,
luteolysis, and uterine contractions. Their gastro-intestinal effects include the
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production of pain, inhibition of acid secretion and stimulation of mucus secretion
(Ophardt, 2003).
Cyclooxygenase Pathway
Arachidonic acid may be metabolized by either of two pathways. One
pathway oxidizes the substrate via lipoxygenase, resulting in the formation of
leukotrienes. In contrast, the second pathway begins with the metabolism of
arachidonic acid by clooxygenase, resulting in the production of prostaglandins
and thromboxanes (Lands, 1979). Cyclooxygenase-1 maintains normal gastric
mucosa and influences kidney function, whereas cylooxygenase-2 promotes
inflammation. Both of these enzymes are able to convert arachidonic acid to
prostaglandins, although investigators have reported that cyclooxygenase-1
(COX-1) requires a higher concentration of arachidonic acid than does
cyclooxgenase-2 (COX-2) (Arosh et al., 2004) and COX-1 causes platelet
aggregation, whereas COX-2 produces prostacyclin, which prevents platelets
from adhering to vessel walls.
Several enzymes control the production of individual prostaglandins, such
as cytosolic phospholipase A2 (cPLA2), cyclooxygenases, and prostaglandin
synthase (Smith and Dewitt, 1996). Phospholipase A2 initiates the release of
arachidonic acid from the phospholipids in the cell membrane, exposing it to the
action of

COX-1 and COX-2. The action of these enzymes is dependent upon

the availability of calcium, which activates phospholipase A2. The COXs convert
arachidonic acid into prostaglandin H2 (PGH2), (Gijon and Leslie, 1999).
Various synthases catalyze PGH2, resulting in the formation of several
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prostaglandins, including PGF2! and PGE2. Both of these prostaglandins use G
protein-coupled receptors to stimulate target tissue.

These receptors are

coupled to phospholipase C, giving rise to two second messengers, inositol
triphosphate (IP3) and diacyl glycerol (DAG). Inositol triphosphate diffuses into
the cytosol and liberates intracellular Ca++ (Narumiya and Ushikubi, 1999) and
DAG remains within the plasma membrane where it activates protein kinase C.
Results of a study by Wiltbank in 1992 suggest that PGF2! acts via the protein
kinase C second messenger system to exert antisteroidogenic effects upon large
luteal cells.
Various Effects
The difficulty in investigating the effect of prostaglandins on physiological
processes is compounded by their transient nature (Lands, 1979). Degrading
enzymes in many tissues result in a loss of activity within one circulation of the
blood (Hansen, 1976; Newcombe, 1975).
The eicosanoids, a term encompassing both the prostaglandins and
thromboxanes, readily break down into inactive products. Thromboxane (TXA2)
is a vasoconstrictor and platelet aggregator, therefore it is antagonistic to
prostacyclin (PGI2), which is a vasodilator and inhibitor of platelet aggregation
(Gryglewski et al., 1976). The arterial wall, corpus luteum, follicle, and uterus
produce copious quantities of PGI2 (Bunting et al., 1977).

In vitro PGI2

production in cardiac tissue is inhibited by nicotine. It is unclear whether this
effect is the result of nicotine per se or the action of prostacyclin synthase
(Wennmole, 1978). Two other prostaglandins interact antagonistically, but are
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also capable of similar effects. PGE2 relaxes smooth muscle of the oviduct,
whereas PGF2! contracts the muscle of the oviduct (Lindblom and Wikland,
1982). However, both of these prostaglandins are capable of causing uterine
contractions, although the threshold concentration of PGF2! required for
contraction is less than that of PGE2 (Villar et al., 1986).
Milvae, in Reviews of Reproduction (2000) enumerates the following
effects of PGF2!: a decrease in luteal blood flow and decrease in number of
small luteal cells, altered activity of steroidogenic enzymes, decreased gene
expression for StAR, increased gene expression of prostaglandin G/H synthase,
inhibition of steroidogenesis, changes in membrane fluidity, and release of
oxytocin by the CL. Conclusions to be drawn from these data are clouded by the
fact that PGF2! effects vary according to species, culture conditions, and cell
types.

For example, if PGF2! is added to dispersed bovine luteal cells, it

actually stimulates progesterone production (Hansel et al., 1991). Possibly, the
action of PGF2! is influenced by the presence of endothelial cells (Auletta and
Flint, 1988) or via the presence of oxytocin (Rodgers, 1990).
Although PGs are lipids, they cannot easily cross cell membranes due to
the presence of charged anions (Schuster VL, 2002). Cellular transporters aid
their passage through membranes. These transporters have 12 transmembrane
domains and are members of the anion transport class of transmembrane
proteins (Tsai and Wiltbank, 1997). Prostaglandin transporter protein (PGT) aids
the relocation of PGF2! and PGE2 from the uterus to the ovary via the uteroovarian plexus. Impaired transport of PGF2! could affect luteolysis and fertility in
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ruminants (Schuster, 1998; 2002; Lee et al., 2010). Transporter components are
primarily expressed in the large luteal cells (Arosh et al., 2004).
PGE2 expresses its effects primarily via the G protein coupled receptors
designated EP1, EP2, EP3, and EP4. Recently, it has been determined that EP2
and not EP4 is the main cAMP- producing PGE2 receptor. The receptor which
binds PGF2! is designated the FP receptor (Arosh et al., 2004).
A viable CL and secretion of progesterone is required for maintenance of
pregnancy in many species.

PGE2 stimulates progesterone as efficiently as

luteinizing hormone (LH) in both the bovine and ovine according to several
sources (Weems et al., 2002 and 1997; Kim et al., 2001). PGE2 increases
progesterone by activation of the cAMP-PKA pathway (Marsh and LeMaire, 1974
; Boiti et al., 2001). The signaling pathway which leads to luteal regression is
complicated and differs among species. PGF2! receptor (FP) causes an
increase in Ca++ and activation of PKC. Intracellular calcium causes cytosolic
phospholipase A2 to be activated and targeted to the nuclear membrane, where
it causes phospholipids in the membrane to release arachidonic acid, which is
converted to PGF2!. Activation of PKC also inhibits progesterone production,
probably by inhibiting StAR protein (Diaz et al., 2002; Anderson et al., 2001; Tsai
et al., 1998).
Intraluteal Production
A current concept asserts that after the secretion of extraluteal and
endometrial prostaglandin, luteal sources of prostaglandin regulate the CL (Davis
and Rueda, 2002). Investigations of Arosh et al., (2004) suggest that locally
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produced luteal PGs complement endometrial and extraluteal availability of PG,
thus influencing the function of the CL.
In the large luteal cells (LLC), arachidonic acid is metabolized into PGH2
by COX-1 and COX-2. PGH2 is then converted into either PGE2 or PGF2! by
PGE synthase or PGF synthase. Prostaglandin transport (PGT) is responsible
for both the egress and entrance of PGE2 and PGF2! through their receptors. In
addition PGT is involved in the transport of PGE2 and PGF2! from the uterus to
the ovary. There are ten known PG receptors, but those of importance in luteal
cells are EP2 and EP3 and FP.
Both PGE2 and PGF2! have specific roles in the maintenance and
regression of the CL.

In the bovine, COX-1, PGF synthase, and PG 15-

dehydrogenase are present at constant levels. However, COX-2, PGE synthase,
PG transporter, EP2, EP3, and FP levels vary depending upon the phases of the
corpus luteum. For example, PGE2 biosynthesis is greater in growing CLs and
lesser in regressing CLs. Biosynthesis of PGF2 increases during regression of
the CL. Thus, PGE2 is active during the maintenance phase of the CL and
PGF2! is active primarily during luteal regression. Biosynthesis of both PGs
occurs primarily in the large luteal cells (Arosh et al., 2004).
There is abundant evidence to support the contention that luteal cells
secrete prostaglandins (Arosh et al., 2004). During early development of the CL
and during luteolysis, secretion of PGs is elevated. Several factors are involved
in this regulation. In several species an “autoamplification” pathway has been
identified which enables PGF2! to induce luteal cells to secret additional PGF2!.
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In various species differing expression of Cyclooxygenase-2 (Cox-2) and
phospholipase A2 may control the process. Decreased progesterone, increased
endothelin-1, as well as increased cytokines, all ensue as a result of PGF2!
secreted by the CL (Arosh et al., 2004).
In the absence of pregnancy, PGF2! from the endometrium initiates
luteolysis between day 15 and 17 of the 21-day cycle in the bovine (McCracken
et al., 1999; Niswender et al., 2000). It has been confirmed by other
investigations that in ruminants, more than 80% of the total progesterone is
produced in the large luteal cells independent of any stimulus from LH (Diaz et
al., 2002; Niswender, 2002). It remains to be determined why the large luteal
cells produce the largest amount of progesterone (Niswender, 2002).

In

ruminants the mechanism responsible for refractoriness of the early CL to PGF2
is unknown. It is speculated, however, that limited availability of PG transport in
combination with increased secretion of PGE2 may explain this refractoriness of
the early CL to luteolysis.
Influence of Various Drugs
The modus operandi of common drugs has been clarified by knowledge of
the biological activities of the eicosanoids. Aspirin, the oldest and most common
drug, inhibits prostaglandin synthesis (Vane, 1971). Indomethacin blocks the
cyclooxygenase pathway when administered twice daily on day 4-6 of the
estrous cycle in heifers (Milvae and Hansel, 1985).

It is speculated that

prostacyclin may exert a luteotropic effect early in the luteal phase.
Phospholipase, which acts upon the phospholipids in the cell membrane, making
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arachidonic acid available, depends upon calcium for eicosanoid synthesis.
Therefore, agents that inhibit calcium availability, such as local anesthetics,
reduce

prostaglandin

production,

probably

phospholipase activity (Kunzl et al., 1974).

by

adversely

affecting

the

Acting in a similar manner,

glucocorticoids inhibit phospholipase A2, thereby decreasing the availability of
arachidonic acid. This action is probably the reason why glucocorticoids exert an
anti-inflammatory effect (Kantrowitz et al., 1974).
Influence of Endothelin-1 (ET-1)
Luteal endothelial cells produce endothelin 1, a potent vasoconstrictor that
interacts with PGF2! to cause luteolysis (Fukada, 1988 and Levin, 1996). There
is abundant evidence that endothelin-1 (ET-1) also inhibits steroidogenesis and
reduces the biosynthesis of both progesterone and prostacyclin (Milvae, 2000).
Support for this theory is afforded by the discovery of receptors for ET-1 on both
large and small bovine luteal cells.

Endothelin 1 reaches its greatest

concentration when PGF2! levels are also increased, at the time of luteolysis,
lending credence to theory that both ET-1 and PGF2! have a role in luteolysis.
When ET-1 was administered to ewes, jugular venous progesterone was
reduced, while the luteal lifespan was not affected. If ET-1 and PGF2! were
combined, however, complete luteolysis and a reduction in the lifespan of the CL
were achieved (Milvae, 2000). However, ET-1, in the absence of PGF2! does
not cause luteolysis in cows (Choudhary et al., 2004a) or sheep (Hinckley and
Milvae, 2001).
Influence of Nitric Oxide (NO)
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Nitric oxide is thought to mediate the luteolytic effect of PGF2! via
unknown mechanisms. An NO donor (SNAP) when injected directly into the CL
caused an increase in blood flow (Miyamoto and Shirasuna, 2009).

Studies in

the cow using the NOS inhibitor, L-NAME, suggest that L-NAME acts by blocking
PGF2!-induced luteolysis (Jaroszewski and Hansel, 2000). In 2003, evidence
supported the contention that L-NAME caused prolongation of the lifespan of the
CL in heifers and increased progesterone (Jaroszewski, et al., 2003).
The earliest physiological sign of the luteolytic cascade in the bovine is
apparent at day 8-12 of the estrous cycle. At this phase of the cycle, PGF2!
reduces progesterone concentrations and decreases the volume of the CL.
PGF2! does not induce luteolysis during the early luteal phase up to day 5 of the
estrous cycle (Hendricks et al., 1974). If PGF2 is available endogenously or
exogenously at day 10, when the CL is mature, there is an increase in blood flow
at the periphery of the CL, (Miyamoto and Shirasuna, 2009), which is followed by
a gradual decrease in blood flow (Acosta et al., 2002). The increased blood flow
in the periphery of the CL on day 17-18 was accompanied by peak levels of
plasma 13, 14 dihydro 15 keto PGF2! (PGFM), a metabolite of PGF2!.
Immediately subsequent to the peak levels of PGFM, progesterone levels
declined (Miyamoto et al., 2005; Shirasuna et al;, 2008c). Blood flow in the CL
increases with each PGFM pulse. This increased blood flow induced by NO is
one of the earliest events during luteolysis in the cow (Miyamoto and Shirasuna,
2009).
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The effect of PGF2! and eNOS on the peripheral and central regions of
the early CL, which is resistant to both PGF2! and luteolysis, was compared to
the mid CL, which is sensitive to PGF2!. Although it appears that PGF2! does
not affect blood flow in the early CL, it is known that PGF2! stimulates the
expression of eNOS mRNA in the periphery, but not in the center of the mid CL
(Shirasuna et al., 2008b). It is hypothesized that PGF2! action depends upon
the phase of the cycle (early versus midcycle) and also on the region of the CL
(periphery versus center of the CL).

In conclusion, PGF2! stimulates the

synthesis of NO which results in increased blood flow in the periphery of the
mature CL (Miyamoto and Shirasuna, 2009). Corroborating the conclusions of
these investigations is an article published in March 2012. The regulation of
angiogenesis genes by prostaglandin in luteal endothelial cells (ECs) varied
depending upon the stage of luteolysis. An increase in prostaglandin on day 11
of the CL adversely affected blood vessels and reduced hormonal output of the
CL (Zalman et al., 2012).
Influence of Oxytocin (OT)
In 1906, Sir Henry Dale found that extracts from the human posterior
pituitary contracted the uterus in a pregnant cat. He named the extract “oxytocin”.
Forty-seven years after Dale’s discovery, oxytocin was sequenced and
synthesized by Vincent du Vigneaud (Magon and Kaira, 2011).

Although

oxytocin exerts multiple effects on various tissues, it is primarily associated with
hastening labor contractions after distension of the cervix and in causing milk to
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be released from mammary glands and enter the ducts of the breast after
stimulation of the nipples (du Vigneaud et al., 1953).
Oxytocin is a nonapeptide (nine amino acids) synthesized in the corpus
luteum (McCracken, 1999) and in the supraoptic and paraventricular nuclei of the
hypothalamus (Ross et al., 2009). It is released into the circulation from the
posterior pituitary.

In addition to its role in the labor process, it promotes

generalized feelings of contentment and aids bonding of the infant and mother
(Meyer, 2007; Marazziti et al., 2006).
In the bovine CL, the expression of oxytocin mRNA is elevated during the
early luteal phase (Ivell et al., 1985; Furuya et al., 1990; Wathes and DenningKendall, 1992). In sheep, oxytocin mRNA is low during the mid to late estrous
cycle (Ivell et al., 1990). PGF2! stimulates OT secretion from the CL (Flint and
Sheldrick, 1982). Oxytocin stimulates uterine secretion of PGF2! (Roberts and
McCracken, 1976).

Therefore, there exists a positive feedback mechanism

between these two hormones.
Summary of the Effects of ET-1, NO, and OT
A consideration of current research has led to the proposal of a possible
sequence of events promoting luteolysis in the bovine. PGF2! is transported
from the ovarian artery to luteal microvessels. PGF2! activates eNOS and the
peptide apelin in the outer, peripheral area of the CL.

Apelin promotes the

formation of new blood vessels and the activation of apelin receptors induces the
release of nitric oxide. This results in an acute increase in blood flow in the
peripheral area as a result of vasodilation induced by NO. The increase in blood
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flow is one of the earliest physiological signs of luteolysis in the bovine. After the
increase in blood flow, PGF2! stimulates the production of endothelin 1 (ET-1)
and angiotensin II as well as additional PGF2! from luteal cells (Milvae, 2000).
These vasoactive molecules (NO, ET-1, angiotensin II, and OT) regulate blood
flow in the CL, thereby expediting luteolysis (Miyamoto and Shirasuna, 2009).
Apoptotic factors, and perhaps PGF2! as we hypothesize in this dissertation,
cause the release of cytochrome c from the inner mitochondrial membrane and
the caspase cascade is generated (Raff, 1998). The direct relationship between
PGF2! and release of cytochrome c remains tenuous, but PGF2! had no
inhibitory effect on the promotion of apoptosis by cytochrome c (Peterson, 1988).
After the onset of the luteal cascade, there exists a positive feedback between
PGF2! and OT. Oxytocin released in a pulsatile manner on days 13-14 in sheep
induces luteolytic pulses of PGF2!

(McCracken et al., 2012).

The strong

vasoconstriction which ensues from ET-1, angiotensin II, and OT is accompanied
by a decrease in progesterone and an increase in apoptosis in both luteal cells
and endothelial cells.
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Chapter IV. Steroidogensis
Cholesterol
Steroid hormones are made from cholesterol, a 27 carbon molecule which
is an important constituent of the cell membrane and a precursor molecule for the
synthesis of steroidal hormones. Steroid compounds contain three cyclohexane
rings and one cyclopentane ring. Functional groups which attach to this structure
confer a variety of functions (Heffner and Schust, 2010).
In 1769, Francois Poulletier de la Salle first identified cholesterol while
observing gallstones (Magee, 1998). The name “cholesterol” originates from the
Greek word for bile and the word “stereos” for solid, reflecting the fact that
cholesterol becomes concentrated in the bile and may settle out, forming
gallstones.
The major site of cholesterol biosynthesis is the liver. Twenty to twentyfive percent of daily cholesterol production occurs in the liver. Other sites of its
synthesis include the intestines, adrenal glands, and reproductive organs. Its
synthesis is governed by homeostatic mechanisms that depend upon dietary
intake and liver production. The greater the dietary consumption of cholesterol
from animal fat sources, the less the liver will synthesize endogenously (Ness
and Chambers, 2000). The primary regulatory mechanism for the synthesis of
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cholesterol is sterol regulatory element-binding protein 1 and 2 (SREBP)
(Grosshans et al., 2006). This sterol is able to sense the amount of intracellular
cholesterol in the endoplasmic reticulum of eukaryotes (Espenshade and
Hughes, 2007).

When SREBP is cleaved, it migrates to the nucleus and

functions as a transcription factor for intracellular cholesterol in the endoplasmic
reticulum. The SREBP pathway regulates the expression of genes that control
all lipid formation (Eberle et al., 2004).
Because cholesterol is unique to animals, it is essential for herbivores,
such as ruminants, to have a cholesterol synthesis pathway. The first compound
in the pathway is acetate, from which all of cholesterol’s carbon atoms are
derived. Synthesis of cholesterol is initiated by acetyl-CoA, an organic compound
in which an acetyl group is attached to a coenzyme. Acetyl-CoA is converted to
hydroxymethylglutaryl-CoA (HMG-CoA) in the cytosol, whereas all subsequent
steps occur in the smooth ER.

When enzymatically reduced, HMG-CoA

synthesizes mevalonate. From this step on, substrates are committed to become
sterolds.

It is for this reason that attempts to regulate the production of

cholesterol are concentrated on manipulating the enzyme HMG-CoA reductase.
Mevalonate, via phosphorylation, produces squalene.
synthesizes lanosterol, the first sterol in the pathway.

Squalene, in turn,
Lanosterol is the

immediate sterol precursor of cholesterol (Dayspring, 2008).
After formation in the liver, cholesterol is concentrated during storage in
the gall bladder, and then released into the small intestine in response to the
presence of lipids in the tract. Its chief function in digestion is the emulsification of
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lipids. Fifty percent is reabsorbed from the intestine and returned to the blood. In
addition to excretion as bile, cholesterol may leave the liver as a lipo-protein
complex called “very low density lipoproteins” (VLDL). As VLDL circulates in the
blood, some of the protein moieties may be removed, forming low density
lipoproteins (LDL).

Lipoproteins have cell-targeting signals that guide the

transport of cholesterol to its target tissues. The peripheral tissues obtain most
of their cholesterol from LDL by endocytosis.

Liver and peripheral tissues

therefore have two means of obtaining cholesterol: synthesis from acetyl-CoA by
the de novo pathway discussed in the preceding paragraph, or they may obtain it
from the blood via endocytosis.

Dietary cholesterol is converted within the

intestine to lipid-protein complexes called chylomicrons.

After removal of

triglycerides from the chylomicrons at the peripheral tissues, remnants of the
chylomicrons may be taken up by receptors in the liver in a manner similar to the
uptake of LDL by the liver (Payne and Hales, 2004).
Cholesterol actually moves back and forth between the liver and
peripheral tissues. While LDL removes cholesterol from the liver, high-density
lipoproteins (HDL) return cholesterol to the liver where excess is excreted as bile
salts into the intestine. In this manner, accumulation of detrimental amounts of
cholesterol may be avoided.
In addition to its role in digestion, cholesterol is an essential component of
the cell membrane.

In contrast to plasma membranes, in which cholesterol

constitutes approximately 20% of the mass of the membrane, in mitochondria it
makes up about 3% of the mass of the membrane. Within the cell membrane,
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the hydroxyl group on cholesterol interacts with the polar head of the
phospholipids of the membrane.

The hydrocarbon chain of the cholesterol

molecule is embedded in the membrane in association with nonpolar portions of
other lipids. Cholesterol confers fluidity to the membrane and also reduces the
permeability of the membrane to hydrogen and sodium ions (Rone et al., 2009).
It accomplishes this feat by separating the phospholipids so that the fatty acid
chains can’t come together and crystallize. Because of the way the cholesterol
molecule is shaped, part of the steroid ring is attracted to the fatty acid tail on the
nearest phospholipid. This helps to stabilize the outer surface of the membrane
and make it less soluble to small hydrophilic molecules. To function properly, the
membrane must be neither too fluid nor too firm. Greater firmness is conferred by
the formation of lipid rafts that associate with larger proteins. A lipid raft contains
concentrated cholesterol and sphingolipids, a type of phospholipid with longer
and more saturated fatty acid tails.

These rafts aggregate, making the

membrane thicker to accommodate proteins which must be in close association
with other proteins in order to function properly. Which proteins exist in lipid rafts
and which do not has not been determined (Alberts, 2002).
Conversion of Cholesterol to Steroid Hormones
The conversion of cholesterol to pregnenolone occurs inside the
mitochondria where the cholesterol side-chain-cleavage enzyme (P450scc)
resides on the matrix side of the inner mitochondrial membrane (Bose et al.,
2002; Stocco, 2001). Thus, P450scc and enzymes of the respiratory electron
transport chain both occupy the inner mitochondrial membrane.
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It has been
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demonstrated that P450scc can function only in the mitochondria (Black et al.,
1994).

Once thought to be the rate-limiting step in biosynthesis of steroids,

P450scc enzymatic activity is now known to partially rely upon the steroidogenic
acute regulatory protein (StAR), which has been localized to the outer
mitochondrial membrane (Stocco, 2001; Strauss et al., 1999).
The first two enzymes in the steroidogenic pathway are P450scc and
3!-hydroxysteroid dehydrogenase (3!-HSD). The latter enzyme converts
pregnenolone to progesterone and is found primarily in the cytosol. However,
recently 3!-HSD has been located within the mitochondria, inferring that some
progesterone may be synthesized within the mitochondria as well (Stocco, 2000;
Chapman et al., 2005). As early as the 1960s, it was determined that 3!-HSD
was located within mitochondrial fractions of ovarian tissue (Jackanicz and
Armstrong, 1968; Sulimovici and Boyd, 1969; and Flint and Armstrong, 1971).
Their data confirmed that conversion of cholesterol to progesterone can occur
within the mitochondria of rat and bovine corpora lutea and perhaps within
mitochondria of other species as well.
P450 Enzymes
With the advent of the 21st century, our understanding of the identification
and characterization of the enzymes involved in steroid hormone biosynthesis
has

advanced

substantially.

Multiple

isoforms

of

3!-hydroxysteroid

dehydrogenase (HSD), which is essential for the synthesis of all steroid
hormones, and 17! - HSD, which is necessary for the final step in biosynthesis
have been identified and cloned (Schuster et al., 2008). By utilization of
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alternative promoters, it has been possible to determine the mode of action of
tissue-specific P450 aromatase, a member of the P450 superfamily, which
converts androgen to estrogen. Although steroidogenic enzymes are associated
primarily with the adrenals and gonads, these enzymes have recently been
identified in the cardiovascular and nervous systems, where they may act in an
autocrine or paracrine fashion (Payne and Hales, 2004).
Although our emphasis in this dissertation is upon those enzymes which
are important in the biosynthesis of steroids in the gonads, there has been
evidence in recent years of de novo synthesis in the nervous system and in
cardiac tissue.

These neurosteroids function as paracrine factors within the

nervous system in contrast to gonadal and adrenal steroids, which are released
into the circulatory system to be transported to their target sites.

As new

techniques become available, it is likely that more peripheral sites of enzyme
expression will be discovered (Mellon and Griffin, 2002).
All the enzymes involved in the biosynthesis of the adrenal steroids:
corticosterone, cortisol, adosterone as well as those involved in biosynthesis of
gonadal steroids: progesterone, estradiol, and testosterone, fall into two major
classes of proteins. These classes are: the cytochrome P450 heme-containing
proteins and the hydroxysteroid dehydrogenases.

Isoforms of 3! - HSD are

homologous in their amino acid composition, unlike the 17! - HSDs that show
very little amino acid homology (Curnow et al, 1991).
trophic hormones differ in their pathways.
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Adrenal and gonadal

Gonadal hormones act via cAMP

!
through a protein kinase A pathway, whereas adrenal glands use a protein
kinase C pathway (Tremblay and Viger, 2003; Kuri, 2009).
The P450 enzymes (re-named the Cytochrome P450 or CYP) are
membrane-bound proteins in contact with either the mitochondrial membranes:
CYP11A, CYP11B1, and CYP11B2 or in contact with the endoplasmic reticulum,
i.e. microsomal: CYP17, CYP19, and CYP21. These heme-containing proteins
are found in bacteria, fungi, plants, and animals (Nelson et al., 1996). When
combined in vitro with carbon monoxide, they absorb light maximally at 450 nm.
The P450s accept two oxygen atoms from nicotinamide adenine dinucleotide
phosphate (NADPH). One oxygen atom binds to the substrate as a hydroxyl
group and the other oxygen atom is reduced to water. Two distinct electron
transfer systems are involved in this transfer. Initially, the mitochondrial transfer
system passes an electron to adrenodoxin reductase, then to adrenodoxin, then
to P450 and finally to the substrate. The microsomal transfer system, which
takes place in the endoplasmic reticulum, involves cytochrome oxidoreductase, a
protein which contains two flavins. In this case electrons are transferred from
NADPH to a flavinadenine dinucleotide, then to flavinmononucleotide, next to
P450 and finally to the substrate (Payne and Hales, 2004).
CYP11A (P450scc)
CYP11A catalyzes the first step in the biosynthesis of all steroid
hormones. Three molecules of oxygen, three molecules of NADPH, and the
mitochondrial electron transfer system are required.

The side-chain on

cholesterol is cleaved between carbons 20 and 22, resulting in the C21 steroid
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pregnenolone (Bose et al., 2002). CYP11A has been detected in all three zones
of the adrenals, the theca interna and granulosa cells of ovulatory follicles,
testes, placenta, central and peripheral nervous systems, and in the human and
rodent heart (Kaves-Wandover and White, 2000; Young et al., 2001).
CYP17 (P450c17)
CYP17 utilizes the microsomal electron transfer system of the ER to
catalyze the hydroxylation of the C21 steroids (pregnenolone and progesterone),
followed by cleavage of the C17-20 bond, to produce the C19 steroids:
androstenedione, androgens, and testosterone.

Each reaction requires one

molecule of NADPH and one molecule of molecular oxygen (Payne and Hales,
2006). CYP17 is expressed in Leydig cells and thecal cells, but not in granulosa
cells (Sasano et al., 1989).
CYP19 (P450arom)
CYP19 converts the C19 androgens, androstenedione, and testosterone
to the C18 estrogens, estrone, and estradiol. Three molecules of oxygen and
three molecules of NADPH are required for this reaction, which uses the
microsomal electron transfer system of the ER (Payne and Hales, 2004).
Regulation and Expression of P450 Steroidogenic Enzymes
The nuclear binding protein, steroidogenic factor -1 (SF-1) (Lala et al.,
1992), also referred to as Ad4BP, (Morohashi et al., 1992), is essential for cellspecific gonadal and adrenal expression of P450 enzymes. ACTH stimulates the
release of the adrenal hormones, whereas LH in the theca, corpus luteum, and
Leydig cells and FSH in the granulosa cells activate adenylate cyclase, thereby
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increasing cAMP and stimulating the synthesis of P450 enzymes. This
stimulation is affected via G protein-coupled receptors (Waterman, 1994;
Waterman and Keeney, 1996). With the exception of CYP17, whose secretion is
wholly dependent upon cAMP, other factors aid in maintaining maximal
expression of the other P450s (Anakwe and Payne, 1987).
Hydroxysteroid Dehydrogenase
One of the chief differences between the P450 enzymes and the
hydroxysteroid dehydrogenases is the fact that all P450 enzymes are coded by a
single nuclear gene.

The several isoforms of the 3!-HSDs and the several

isozymes of 17!-HSDs are each coded by separate genes. Both the 3!-HSDs
and the 17!-HSDs are involved in the reduction and oxidation of steroid
hormones that require NAD+/NADP+. The 17!-HSDs catalyze the final reaction
in the biosynthesis of estradiol and testosterone. The isomerases are found in
both mitochondrial and microsomal membranes depending upon the type of cell
in which they are expressed. Since they are numbered in the order of their
discovery, it is not possible to ascribe the same characteristics to similarly
numbered isoforms found in different species (Simard et al., 1996; Payne et al.,
1997; Ahhaszade et al., 1997). The 3!-HSDs are required for the production of
all steroid hormones except pregnenolone.

The localization of 3!-HSDs within

the mitochondria has been determined in bovine adrenal cells and rat adrenal
cells (Cherradi et al., 1997). The significance of finding 3!-HSD within the
mitochondria leads to the supposition that some pregnenolone is converted to
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progesterone before exiting the mitochondria. The HSDs have been studied
much more extensively in the human, mouse, and rat than in other species.

Intracellular Pathways of Cholesterol Transport
The 37 kDa precursor of steroidogenic acute regulatory protein (StAR) is
synthesized in the cytoplasm, accompanied by chaperone proteins which prevent
its folding. In the unfolded form, the precursor is able to gain entrance through
the outer mitochondrial membrane. Upon entrance, cleavage of the precursor by
proteases in the mitochondrion convert the immature 37 kDa form to the mature
30 kDa form of StAR.
The presence of a “sterol-binding pocket” on StAR can accommodate one
molecule of cholesterol when it is in contact with the outer membrane (Miller and
Auchus, 2011). When StAR ceases to be in contact with the outer membrane,
cholesterol transport ceases (Stocco, 2000).

StAR is dependent upon

transporter protein (TSPO) for its import into the inner membrane (Rone, 2009).
Translocator Protein (TSPO) is an 18 kDa protein located on the outer
mitochondrial membrane. Initially determined to be a secondary binding site for
diazepam, it was called Peripheral Benzodiazepine Receptor (PBR), a term
which is still in use. However, subsequent research has expanded greatly what
is known regarding its many functions. It is expressed throughout the body and
in small amounts in the brain. TSPO is a biomarker of gliosis and inflammation
associated with several neuropathologic disorders.

Recent investigations

support the idea that TSPO ligands may act to facilitate healing of brain injury. In
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addition, TSPO acts to reduce anxiety and panic attacks without causing
sedation or withdrawal problems (Chen and Guilarte, 2008). Upregulation of
TSPO has been confirmed in multiple sclerosis, Parkinson’s disease,
Huntington’s disease and Alzheimer’s disease, thus it has been possible to use
TSPO as a marker to diagnose and follow the progression of many diseases
(Rone et al., 2009).
In 1986, TSPO was localized to the outer mitochondrial membrane (Anholt
et al., 1986). In addition to its association with steroid synthesis in adrenal,
placental, testicular, ovarian and glial cells (Brown and Papadoupoulos, 2001;
Papadopoulos et al., 2001; Lacapere and Papadopoulos, 2003; Giatzakis and
Papadopoulos, 2004), it has a role in such disparate functions as induction of
apoptosis in colorectal cancer cells, (Batarseh and Papadopoulos, 2010),
modification of the immune system, regulation of cell proliferation, transport of
porphyrin. In addition, it assists the entrance of cholesterol through the outer
mitochondrial membrane (Casellas et al., 2002). A ligand of TSPO, Ro5-4864,
reduces reactive oxygen species (ROS) cell damage. Therefore, a beneficial
effect of this TSPO ligand may prevent aging-associated peripheral nerve
damage (Leonelli et al., 2005).
Of special interest to us is the ability of TSPO to bond with strong affinity
to cholesterol and to aid in transport of cholesterol across the outer mitochondrial
membrane (Papadopoulos et al., 1997). It is an essential partner with StAR in
the early steps in steroidogenesis. There are several steps whereby StAR is
transferred through the outer membrane and into the inner membrane of the
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mitochondrion, while TSPO regulates the translocation of cholesterol into the
inner mitochondrial membrane. It is unclear how cholesterol binds to P450scc
after it moves to the membrane (Rone, 2009).
Research since the early 2000s has clarified the role of both StAR and
TSPO. StAR cannot accomplish the transport of cholesterol without the
assistance of TSPO (Jefcoate and Artemenko 2004). The outer mitochondrial
membrane of steroidogenic cells contains abundant receptors for TSPO. These
receptors have been localized in the mitochondrial permeability transition pore of
the outer mitochondrial membrane (Marselli et al., 2004), where the receptors
associate with the porin family of channel proteins. When porins are activated by
agonists or acetyl CoA binding protein, their permeability is altered.

Thus,

mitochondria are able to alter permeability of these channel proteins (Jefcoate
and Artemenko, 2004). Entrance of cholesterol into the mitochondria may be
affected by the activity of these porins, since receptors for TSPO are located in
their vicinity,
It may be assumed that transport of cholesterol across the aqueous intermembrane space occurs with difficulty. This is just one of the many questions
which require further investigation. The study of the process in yeast has yielded
some insights, which may be applied to other organisms (Cyr and Neupert, 1996;
Koehler et al., 2000).

After translation in yeast, immature StAR p37 is

phosphorylated, causing the enzyme to unfold from its prior conformation. In its
unfolded state it is able to pass through channels in the outer mitochondrial
membrane and inner mitochondrial membrane and refold in the mitochondrial
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matrix, forming the mature StAR p30. It is hypothesized that mature StAR p30
aids the relocation of cholesterol from inner mitochondrial membrane sites which
are in close proximity to the outer membrane to tubular sites on the inner
membrane where P450scc is located. Tubular protrusions and buds can be seen
on the inner mitochondrial membrane with scanning electron microscopy. These
buds increase the surface area, creating more space for steroidogenic enzymes
and possibly allowing for separation from respiratory domains (Jecoate and
Artemenko 2004; Riva et al., 2003). It is further conjectured that stimulatory
effects of free fatty acids on the metabolism of cholesterol by P450scc may assist
translocation of StAR to the inner membrane (Dhariwal et al., 1989). Thus, fatty
acids may accumulate in proximity to StAR.
Many questions remain to be answered by further investigation.

The

complex process of cholesterol transport is regulated at many points by several
signaling pathways. A balance must be maintained between cytoplasmic transfer
of cholesterol and its transfer into the mitochondria to avoid the accumulation of
excess cholesterol within the mitochondria. Reference has been made to the
protein-protein complex involved in cholesterol transport. A water-soluble form of
cholesterol, 22-R-hydroxycholesterol, induced pregnenolone synthesis 20-fold
(Lui, et al., 2006. Questions arise regarding the origin of the cholesterol used in
steroid synthesis. It has long been assumed that cholesterol is made available
via lipid droplets and the plasma membrane. DiBartolomeis and Jefcoate (1984)
proposed the presence of pools of cholesterol in the mitochondria that are able to
support steroidogenesis for the first few minutes.
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It is currently thought that
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these pools can sustain steroidogenesis longer than a few minutes (Lui, 2006).
Recent technical advances must be brought to bear on other questions.
Characteristics of the two primary forms of cholesterol, LDL (low density
lipoprotein) and HDL (high density lipoprotein), vary considerably.

The main

function of LDL is to transport cholesterol to tissues and arteries, whereas HDL
transports cholesterol from tissues and arteries to the liver and other organs for
storage. LDL is a larger compound than HDL and therefore may enter
mitochondria via endocytosis. Since Cholesterol in the form of HDL is a smaller
compound, it may pass into the mitochondria directly bound to esters,
compounds produced by a reaction between an acid and an alcohol (Maxfield
and Wustner, 2002).
Experiments in yeast suggest that the second messenger, cAMP binds to
protein kinase A and subunits are released, causing phosphorylation of StAR
(Cyr and Neupert, 1996; Koehler et al., 2000). Hormonal signals are thereby
amplified. The mechanism whereby amplification occurs is unknown. A binding
protein located mainly in the Golgi apparatus (PAP 7) binds to both PKA and
TSPO. Li et al., (2001) hypothesizes that PAP7 may be involved in p37 StAR
phosphorylation. Cholesterol likewise binds to TSPO and enters the inner
mitochondrial membrane via voltage dependent anion channels (VDAC). There
are contact sites between the outer and inner membrane at the location of TSPO
binding. Located in the inner membrane is the side-chain cleavage enzyme,
P450, which cleaves the bond between carbon 20 and 22, removing these from
the cholesterol molecule and yielding pregnenolone (P). Failure at any point in
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this chain of events would prevent the synthesis of pregnenolone and the
subsequent synthesis of progesterone. Extrapolation of these data to organisms
exclusive of yeast should be considered with caution.
Several

comparisons

can

steroidogenesis and respiration.

be

made

between

the

processes

of

First of all, both occur on the inner

mitochondrial membrane. The path of electron flow in steroidogenesis involves
NADPH and FÅDH2 (nicotinamide nucleotides or flavin nucleotides) and a series
of oxidation/reduction reactions. The path of electron flow in respiration involves
a compound similar to NADPH, NADH. The respiratory electron acceptors carry
electrons from catabolic reactions to the electron transport chain and the
steroidogenic electron acceptors carry electrons to anabolic reactions.

Cells

maintain separate groups of NADH (respiratory electron acceptor) and NADPH
(steroidogenic electron acceptor).

Neither acceptor can cross the inner

mitochondrial membrane. Presumably, they are located in disparate positions on
the membrane.

The exact location remains to be determined. The inner

membrane is thus essential for these two processes that have an effect upon the
corpus luteum: respiration and steroidogenesis.
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Chapter V. Respiration
Overview
Cellular respiration consists of a series of metabolic reactions that take
place primarily in the mitochondria for the purpose of converting biochemical
energy from nutrients into adenosine triphosphate (ATP), releasing carbon
dioxide and water as waste products. Cells store and use the energy in the
bonds of ATP, which is synthesized primarily in the mitochondria. Adenosine
triphosphate (ATP) supplies the energy required to maintain all body processes.
The first stage of cell respiration, glycolysis, occurs in the cytosol. Since oxygen
is not involved, this initial stage is anaerobic.

Although a total of 4 ATP

molecules are generated, 2 ATP molecules are expended in the formation of two
molecules of nicotinamide adenine dinucleotide (NADH) as well as the synthesis
of one molecule of pyruvate. Pyruvate enters the mitochondrial matrix where it is
oxidized to acetyl-CoA.

It is within the mitochondrial matrix that the second

stage, the “citric acid cycle” or “Krebs cycle” takes place. One glucose molecule
undergoes a series of oxidation reactions that generate 2 ATP, 6 NADH and 2
FADH2 upon the completion of the cycle. The first carrier is nicotinamide adenine
dinucleotide (NAD), which becomes reduced to 6 molecules of NADH.

The

second carrier is flavin adenine dinucleotide (FAD), which becomes reduced to
two molecules of FADH2 (Verkhovsky et al., 1996). These last two products of
the Krebs cycle (NADH and FADH2) are released from the mitochondrial matrix
and participate in the last phase of cell respiration, the electron transport chain,
donating electrons and hydrogen atoms which provide energy for the generation
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of almost all the ATP required for cell processes by the process of chemiosmosis
(Babcock and Wikstrom, 1992).

This process creates a proton gradient that

enables the synthesis of ATP from ADP and phosphate. Since ATP molecules
cannot be stored for long periods of time, cellular respiration must constantly
regenerate ATP. Each ATP molecule releases 7.3 kilocalories of energy per
mole (Crofts A, 1996).
In 1948, Eugene Kennedy and Albert Lehninger discovered that
mitochondria are the site of oxidation phosphorylation in eukaryotes. Thus began
the modern study of biological energy transductions.

Mitochondria have two

membranes. The outer mitochondrial membrane (OMM) is easily permeable to
small molecules and ions, which can move freely through transmembrane
channels

formed

by

!porins!,

integral

membrane

proteins.

The

inner

mitochondrial membrane (IMM) is relatively impermeable. Specific transporters
are required to traverse the IMM.

Protons cross the membrane as part of

antiport transport mechanisms, for example Ca++, Fe++, K+, and Na+ (Scheffler,
2000).
The mitochondrial respiratory chain contains sequentially acting electron
carriers, most of which are integral proteins that accept one or two electrons.
In addition to nicotinamide adenine dinucleotide (NAD) or NADP, other electron
carriers function in the chain: hydrophobic ubiquinone, which is lipid-soluble and
cytochromes. Ubiqunone can accept one or two electrons. It can freely diffuse
within the lipid bilayer of the IMM. Because it can carry both electrons and
protons, it can couple electron flow to proton flow. Mitochondria contain three
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classes of cytochromes: a, b, c, named for differences in their light-absorption
spectra.
In the electron transport chain, electrons move from NADH, succinate,
ubiquinone, cytochromes and eventually to oxygen. Each carrier down the chain
is more electronegaive than the preceding carrier.
The constituents within the inner mitochondrial membrane that perform
oxidation/reduction reactions are referred to as “complexes”. The first protein to
receive two electrons from NADH is NADH dehydrogenase located in Complex I.
This electron transfer drives the expulsion from the matrix of four protons. A
mobile carrier called ubiquinone passes the electrons to Complex II, but unlike
subsequent carriers, ubiquinone does not expel any protons into the space
between the inner and outer membranes. Succinate (which was synthesized in
the Krebs cycle) is the only component of the transport chain that takes part in
both the Krebs cycle and the electron transport chain. Succinate enters the
transport chain at Complex II and donates electrons to FAD. Each passage of
electrons is accompanied by the expulsion of a proton into the space between
the membranes. The electrons are carried from Complex II to Complex III by
another carrier, cytochrome c. Cytochrome c is a small, heme-containing soluble
protein, which freely diffuses within the membrane, carrying one electron from
Complex II to Complex III. However, unlike the other carriers, cytochrome c
transports only one electron at a time (Voet and Voet, 2004).
Some of the hydrogen protons are combined with oxygen at Complex IV,
producing water. Oxidation of NADH and FADH2 and the phosphorylation of
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ADP are coupled by a proton gradient, which has developed across the inner
membrane. When electrons are transferred from donor to acceptor through this
series of protein complexes, the energy released as they flow through the
transport chain is used to transport protons across the inner membrane, where
they accumulate in the space between the membranes in a process called
“chemiosmosis” (Mitchell, 1961). Chemiosmosis generates potential energy in
the form of a pH and electrical gradient formed by ions, which pass through the
large, mushroom-shaped ATP synthase complex sometimes designated
Complex V. This enzyme completely penetrates the membrane.

The “stem”

portion of ATP synthase is capable of rotating and with each rotation ADP is
phosphorylated to ATP (Campbell et al., 2006). The current model of ATP
synthase (alternating catalytic model) uses the force of movement of protons
across the inner membrane to drive the synthesis of ATP.

ATP synthase

undergoes a conformational change, which results from the rotation of one of its
subunits.

As hydrogen protons enter this structure from an area of high

concentration to an area of low concentration, the ATP rotator turns, producing
the energy for the synthesis of ATP from ADP and phosphate. Thus, energy
stored in the proton gradient drives the synthesis of ATP from ADP and
phosphate (Nakamoto et al., 2008). Estimates of the number of protons required
to synthesize one ATP molecule range from three to four (Voet and Voet, 2004).
As a result of these oxidation-reduction reactions approximately 36-38 molecules
of ATP are synthesized.
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The original model for how complexes are arranged has recently been
questioned.

The complexes may form supercomplexes or !respirasomes!

(Heinemeyer et al., 2007).

According to this model, the complexes form

organized sets of interacting enzymes. Possibly, this might permit more efficient
channeling of substrates between complexes. However, the disagreement over
these respirasomes is on-going, since some data do not conform to this model
(Schagger and Pfeiffer, 2000).
Inhibitors
Several common drugs and toxins are known inhibitors of oxidative
phosphorylation.

An explanation of how some of the more commonly used

inhibitors affect the respiratory process will aid understanding of some research
paradigms.
Cyanide binds to the iron groups in cytochrome oxidase, thereby inhibiting
the electron change by halting all oxidation/reduction reactions. Proton pumps
cannot function (Illingworth, 2012). Azide exerts an effect which is similar to
cyanide. It binds more strongly than oxygen to cytochrome c oxidase, thereby
preventing the reduction of oxygen (Tsubaki and Yoshikawa, 1993).
Rotenone impairs Complex I by preventing the transfer of electrons from
Complex I to ubiquinone by blocking its binding site (Lambert and Brand, 2004).
The affinity of the electron chain for carbon monoxide is lower than that for
oxygen. However, it still exerts a detrimental effect by inhibiting cytochrome
oxidase (Illingworth, 2012).
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Antimycin inhibits the flow of electrons from cytochrome b to cytochrome
c1 at Complex 3, thus preventing the reduction of cytochrome c and the oxidation
of both NADH and succinate (Illingworth, 2012).
Another disruptor of cell respiration is 2,4-dinitrophenol, which interferes
with the proton gradient by carrying protons across the inner mitochondrial
membrane, thereby uncoupling proton pumping from the synthesis of ATP
(Heytler, 1979).
Oligomycin is an antibiotic which binds to ATP synthase, the last enzyme
in the electron transport chain, thus preventing State III respiration. State III is
defined as ADP-stimulated respiration. As energy in the electrical gradient is
used up, ADP binds to ATP synthase. In the presence of inorganic phosphate,
which also binds ATP synthase, a channel is opened in the ATP synthase
complex that allows protons into the matrix from the inner mitochondrial
membrane. As energy in the gradient is removed, the electron transport chain
speeds up, producing more ATP. Oligomycin blocks the proton channel in the
ATP synthase, thereby completely preventing STATE III respiration, which
requires ATP (Joshi and Huang, 1991). The respiratory effects are not
immediate, but become apparent after several minutes (Joshi and Huang, 1991).
Malonate and oxaloacetate are competitive inhibitors of Complex II.
Malonate inhibits succinate dehydrogenase by binding to its active site without
reacting and therefore competes with succinate. Oxaloacetate is also an inhibitor
of Complex II (Heytler, 1979).
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Comparison of Electron Carriers
There are both similarities and dissimilarities between electron carriers
involved in the respiratory chain and electron carriers in the steroid P450 system.
Although some enzymes are embedded in the inner mitochondrial membrane, in
both the respiratory and steroidogenic systems there are small peripheral
enzymes that act as electron carriers. It is postulated that this may afford faster
diffusion of surface proteins in contrast to those within the membrane.

The

membrane has a high protein content, which may impede electron transport. For
example, the diffusion rate of cytochrome c is ten times faster than complexes
embedded in the membrane (Gupte, et al., 1984).
Mitochondrial P450 systems bear similarities to the respiratory oxidative
phosphorylation system in several respects.

The respiratory system is

composed of four complexes (I-IV), which are embedded in the inner
mitochondrial membrane.

Cytochrome c is a small protein, which is not

embedded, but is located on the side of the intermembrane space. This is also
true of another small electron transfer protein, ubiquinone, of the respiratory
transfer system.

All three proteins of the mitochondrial P450 systems are

integral membrane proteins, whereas adrenodoxin and adrenodoxin reductase
are mobile and soluble in the matrix (Hanukoglu et al., 1981a, 1981b). In this
regard, therefore, they may be compared to cytochrome c and ubiquinone of the
respiratory transfer chain.
Electron transfers between Complex III and Complex IV are mediated by
cytochrome c.
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Transfers between Complex I, II, and III are mediated by
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ubiquinone, another small protein.

Since cytochrome c binds both to its

reductase on Complex III and oxidase on Complex IV it must be capable of
moving between the two complexes.

In this regard, cytochrome c in the

respiratory chain behaves in a similar manner to adrenodoxin in the
steroidogenic system. Both are capable of movement and are not, therefore,
integral components of the membrane (Capaldi, 1982 and Gupte et al., 1984).
Since oxidative phosphorylation enzymes and steroidogenic enzyme
levels increase in concert, it seems likely that their regulation is correlated. This
is understandable, since increased steroid synthesis necessitates an increase in
the requirement for energy.
Reactive Oxygen Species (ROS)
Reactive oxygen species are generated during cellular respiration and
steroidogenesis.
Electron transfer may be “coupled” (all electrons from NADPH used to
hydroxylize the substrate) or “leaky” (some electrons transferred to oxygen). In
the latter instance, oxygen radicals are generated as a result of the amount of
NADPH oxidized exceeding the amount of substrate hydroxylated. The reactivity
of these oxygen radicals is due to their unpaired valance electrons. Experiments
have shown that P450 proteins can oxidize NADPH even when steroid substrate
is not present (Rapoport et al., 1995). Since NADPH is required for many
reactions within the mitochondria in addition to its role in the respiratory transport
chain, a basal level is necessary for normal cell function. It appears, therefore,
that the creation of oxygen radicals is unavoidable. Oxygen is the acceptor of
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leaky, uncoupled electrons, producing a superoxide radical (Hanukoglu et al.,
1993). Two superoxide radicals are able to react with two protons, producing
hydrogen peroxide in a reaction termed a “dismutation”. Hydrogen peroxide may
be converted to benign substances such as oxygen and water by catalase and
superoxide dismutase. However, it is likely that some peroxides will persist in the
cell. The leakage of electrons from mitochondria during the respiratory electron
transfer chain is the primarily source of these reactive oxygen radicals (ROS),
(Genova et al., 2003).
Cells defend themselves against ROS damage with enzymes such as
superoxide dismutases, catalases, lactoperoxidases, and small molecule
antioxidants such as ascorbic acid (vitamin C), tocopherol (vitamin E), uric acid
and glutathione. These substances either neutralize or scavenge free radicals
(Hanukoglu, 2006).
The deleterious effects of ROS include damage to proteins, lipids and
DNA. ROS is generated when cells are actively proliferating and progesterone is
being synthesized. The generation of free radicals contributes to apoptotic cell
death, which occurs during luteolysis (Behrmann et al., 2001). Evidence from
several sources indicates a decrease in antioxidant levels as the corpus luteum
regresses, although the results are not consistent (Hanukoglu, 2006). In addition
to ROS, there are many other factors involved in luteolysis (Amsterdam et al.,
2003; McCracken et al, 1999).
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Rationale and Methodology
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Chapter VI. Hypothesis and Objectives
Rationale for Investigating Effects of PGE2 and PGF2!
Our investigations have focused on two prostaglandins: PGE2 and PGF2!
and their effects upon cell respiration and progesterone synthesis. This choice
was partially dictated by a literature search, which revealed the complex and
conflicting influence of these two prostaglandins upon cell respiration and
steroidogenesis. It is apparent that there is ample ambiguity to justify further
investigation. The present study has been conducted to clarify the mode of action
of these two prostaglandins in bovine corpora lutea. It is noteworthy that we
have found no mention in the literature of the effect of PGE2 or PGF2! upon
oxygen consumption of mitochondria isolated from bovine corpora lutea. In view
of the fact that respiratory distress could contribute to the process of luteolysis, it
was decided to pursue this avenue in our research. We believe that the current
study constitutes new, important data on the influence of PGE2 and PGF2! on
cellular respiration.

Hypothesis
The addition of PGE2 or PGF2! to mitochondria obtained from bovine
corpora lutea will affect oxygen consumption and the secretion of progesterone.

!

"#!

!
Objectives
The overall objectives of this study were:
1. To determine the effect of PGF2! or PGE2 on oxygen consumption by
mitochondria isolated from bovine corpora lutea.

2. To determine the effect of PGF2! or PGE2 on the synthesis of
progesterone by mitochondria isolated from bovine corpora lutea.
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Chapter VII. Materials and Methods
Mitochondrial Isolation
Mitochondria were isolated from firm, well-developed bovine corpora lutea
obtained from Applied Reproductive Technology, Madison, WI. All procedures
were carried out at 4°C. Corpora lutea were removed from ovarian tissue,
minced, and washed with isolation buffer (250 mM sucrose, 1mM EGTA, 10 mM
Tris, o.1% BSA, and the pH adjusted to 7.4). Following washing, 15 g of minced
tissue was suspended in 150 ml of isolation buffer and subjected to two
homogenization processes. The first of these was accomplished in a Kontes
Duall grinder (Vineland, New Jersey) with several passes, whereas the second
homogenization was performed using a Wheaton Potter-Elvehjem grinder
(Millville, New Jersey) with several passes. Pestles for these grinders were
driven by a heavy-duty drill at 1400 rpm. After homogenization, contents were
centrifuged for 10 minutes at 3000 rpm (452.5 g) to remove cellular debris. The
pellet was discarded and the supernatant centrifuged for 10 minutes at 7500 rpm
(2830 g). After the second centrifugation, the pellet was saved, and washed with
suspension buffer. The pellet was transferred to an eppendorf tube with 1000 µl
of suspension buffer (250 mM sucrose, 10 mM HEPES, pH 7.4). Protein content
was measured using a Bicinchoninic Acid Protein Assay Kit B9643 (Sigma
Chemical Co, St. Louis MO). The Bicinchoninic Assay consists of two reagents:
Reagent A (Sigma B9643) and Reagent B (Sigma C2284). Reagent A contains
1 g sodium bicinchoninate, 2 g sodium carbonate, 0.16 g sodium tartrate, 0.4 g
NaOH, and 0.95 g sodium bicarbonate. These components were added to 100

!

"#!

!
ml distilled water and adjusted to pH 11.25. Reagent B contains 0.4 g cupric
sulfate in 10 ml distilled water. Reagent A, 100 volumes, is mixed with 2 volumes
of reagent B. Samples are read at 562 nm. This test is based upon the principle
that complexes between copper ions and peptide bonds will produce a purple
end product.
Characterizing Mitochondrial Function
In the current investigation, mitochondrial function was characterized
using oxygen consumption studies and also via staining to visualize outer
membrane integrity.
Oxygen Consumption Measurement
Mitochondrial oxygen uptake was determined using a Clark electrode. The
Clark electrode operates on the principle that reduction of oxygen will generate a
current. The current decreases if oxygen consumption increases. Therefore, the
current is directly proportional to the amount of oxygen in a solution. Oxygen
consumption was expressed as nanomoles of oxygen consumed per minute per
mg of mitochondria. The resulting decrease in voltage (mV) was graphed and
analyzed to determine oxygen consumption.
The Clark electrode was attached to a water bath maintained at 37 °C and
connected to a computer and data logger. Incubation buffer provided oxygen to
the incubation chamber, which was stirred with a 10 mm magnetic bar at 600
rpm. Oxygen consumption of mitochondria was recorded at pH 7.4 in incubation
buffer (250 mM sucrose, 5mM KH2PO4, 5mM MgCl2, 0.1 mM EDTA, 0.1% BSA,
20 mM HEPES).
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Mitochondrial Staining
Further verification of the health of the mitochondria and the integrity of
the outer membrane was obtained by use of a hemocytometer to view
mitochondria at 440 magnification. The mitochondria were stained with Janus
Green B (Ward!s #9458601; 1% aqueous solution), a vital stain, which is the
preferred stain for mitochondria, since it changes color according to the amount
of oxygen present. Mitochondria stain blue in its presence, indicating the
presence of oxygen. Our intention was to verify the presence of healthy
mitochondria, since the mitochondria stain pink if the membrane is compromised.
Our diluted solution contained 10 µl mitochondria (14,425 mitochondria),
10 µl Janus Green B dye, and 80 µl suspension buffer. The suspension buffer
consists of 21.4 g sucrose, 0.691 g HEPES at pH 7.4. Mitochondria were
observed via the use of a hemocytometer. The area of each small square = 0.04
mm3, depth = 0.1 mm. Area x depth = volume per square. Volume per square
multiplied by the number of squares counted = the number of mitochondria per
mm3. Lastly, this number is multiplied by the dilution factor. When oxygen is
present in the medium, the dye takes on a blue color (Lazarow and Cooperstein,
1953).
It is extremely difficult to view mitochondria, whose average size ranges
from 0.5 to 10 µm and whose numbers are estimated to average 1000 – 2000
per liver cell (Marinos and Billet, 1981). Liver cells contain the greatest number
of mitochondria, although the number varies greatly depending upon type of cell
and species. Our estimate was approximately 1,442.50 mitochondria/µl of
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suspension buffer and dye (! 100 µl). The mitochondria were stained a dark
blue, which facilitated observation. It was doubly difficult to observe pink
mitochondria, but it can be stated that there were very few. The chief value of
this staining exercise was to verify that the outer membranes of the mitochondria
were intact.
Determining the Oxygen Consumption Rate
Oxygen consumption rate (OCR) was calculated. OCR respiration is
defined as in vitro oxygen consumption by isolated mitochondria in a substrate
(frequently succinate) in the absence of ADP or any inhibitors. The rationale for
determining the OCR is to permit measurement of the rate of electron transport
when dissolved oxygen is reduced to water.

The significance of oxygen

reduction is that it removes electrons, allowing the carriers, NADH, which
donates electrons to Complex I, and FADH2, which donates electrons to
Complex II, to be re-oxidized. Thus, the electron chain is essentially an energy
converter that harnesses the flow of electrons to the pumping of hydrogen ions
across the inner membrane and into the intermembrane space. This separation
of electrons on one side of the inner membrane and hydrogen ions on the other
side of the membrane results in an electro-chemical gradient. Damaged
mitochondria cannot maintain the gradient. Every in vitro preparation will include
a small proportion of damaged mitochondria. Such mitochondria are referred to
as “uncoupled”, since the gradient is no longer coupled to the synthesis of ATP.
Although damaged, such mitochondria are capable of consuming oxygen but not
capable of synthesizing ATP. OCR respiration does not exist in vivo, because
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undamaged mitochondria will not halt activity at Complex IV, but continue the
process to Complex V and the synthesis of ATP.
The OCR is determined by measuring points on the graph generated by
the Clark electrode, indicating the decline of millivolts. See Figure 1 for a pictorial
representation of the graph and the equation used to determine the OCR.
Progesterone Determination
Preparation of mitochondria for the steroidogenesis trials was identical to
the mitochondrial preparation for the respiration trials, as stated in Chapter VII.
A hydroxylated derivative of cholesterol, 22R-Hydroxycholesterol (Sigma
HP384) was chosen in preference to cholesterol for our substrate, since it had
been used successfully in investigations similar to ours (Fitz et al., 1993; Arikan
and Yigit, 2009).

Hydroxycholesterol is slightly soluble in water, but readily

soluble in ethanol. Therefore, 6-7 µl ethanol was added to our protocol.
Progesterone formation was determined according to Vizcarra et al. 1997.
Progesterone

was

quantified

using

a

solid

phase

RIA

(Coat-A-Count

progesterone kit, Diagnostic Products Corp., Los Angeles, CA). When different
concentrations of plasma were assayed, concentrations were parallel to the
standard curve.
Standardizing the Substrates and Prostaglandin Concentration for Oxygen
Consumption and Progesterone Determination
Incubation buffer (1000 µl ! 1 ml) was added to the Clark electrode as our
control (see page 85 for chemical constituents). Isolated mitochondria (30 µl; 1.5
mg/ml ! 45 µg; 1.5mgml) were added to the incubation buffer and allowed to

!

""!

!
stabilize for one minute. In the incubation medium either PGF2! or PGE2 (0.75
or 1.0 µM, (final concentration " 3500 pg/ml) was added and the contents
stabilized for 3 minutes. Succinate (20 µl; 20 mM, final concentration), (Fisher
S413) was dissolved in distilled water and added after 5 seconds to the Clark
electrode.

Ten µl of a known respiratory inhibitor, antimycin, (.02 mM, final

concentration in ethanol) (Sigma A-864), was added after 5 seconds in one or
two of our trials to ascertain activity of our mitochondria.
The concentration of antimycin and succinate was based upon that used
by other investigators.

We were guided by the results of an experiment by

Bowolaksono (2008), in our choice of 1 µM concentrations for both PGF! and
PGE2. Beta Nicotinamide adenine dinucleotide 2# phosphate, NADPH (25 µl;
1mM, final concentration), (Sigma N6505) was added to our progesterone trials.
We determined the appropriate molar concentration of our reagents by
performing an initial experiment (Figure 3). The number of µl of mitochondria
used in each trial was dependent upon the results of our Bicinchoninic Acid
(BCA) analysis, which determined the protein content of the mitochondria.
Statistical Analysis
The experimental design was a completely randomized design and the
data were analyzed using Proc Mixed procedure of SAS using type 3 tests of
fixed effects. Results were considered significant at p < 0.05.
Trials were performed in duplicate and repeated three times in respiration
experiments. Trials were performed in duplicate and repeated four times in
progesterone experiments.
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Chapter VIII. Results and Discussion
Prostaglandin Influence on Oxygen Consumption
Figure 1 aided our analysis of data in the determination of oxygen
consumption rate. Two points on the curve just after succinate addition were
selected and the oxygen consumption rate was calculated using the equation
shown.

This calculation was performed on 115 graphs from each individual

experiment and used to support our conclusions regarding the effect of
succinate, antimycin, and prostaglandins on mitochondrial oxygen consumption.
Additional details pertaining to oxygen consumption are illustrated in
Figure 2. This experiment was repeated a minimum of ten times. Incubation
buffer was added to the Clark electrode and allowed to stabilize for 60 seconds
prior to the addition of mitochondria. After the addition of mitochondria, a slight
decrease in voltage (indicative of increased oxygen consumption) was noted.
The addition of succinate caused an increase in OCR (p < .0001) in the average
oxygen consumption.

Mean oxygen consumption prior to the addition of

succinate as measured by mV, was 100.0 ± 0.5 mV compared to 74.5 ± 0.5 mV
after succinate addition. Antimycin, a known inhibitor of oxygen consumption,
was added after 120 seconds.

As time continued, it was clear that oxygen

consumption was compromised with the addition of antimycin (p < .0001) even
when a known stimulator (succinate) was added, averaging 96 mV ± 0.5. The
drop in voltage as oxygen consumption increased was attributed to the addition
of succinate, indicating that our mitochondria are viable, as succinate is a known
stimulator of mitochondrial function. Antimycin reduced the drop in mV caused
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by succinate as oxygen consumption decreased, again confirming that our
mitochondria are functional. All further data were converted to nanomoles of
oxygen consumption instead of mV, as in Figure 2.
The influence PGF2! on OCR from mitochondria isolated from bovine
corpora lutea is illustrated in Figure 3. Nanomoles of oxygen consumed per
minute per mg of mitochondria were significantly increased by the addition of
succinate, averaging 2 ± 3.5 versus 84 ± 3.5 nm respectively prior to and after
succinate addition. PGF2! was added to achieve 0.01 !M PGF2!, which failed
to inhibit succinate stimulated OCR, averaging 79.0 ± 3.5 nm. However, when
PGF2! was added to achieve 1 !M or 10 !M PGF2!, OCR was reduced (p <
.0001) by approximately 50%. Oxygen consumption was 38.0 ± 3.5 and 36.0 ±
3.5 nm respectively for 1 !M and 10 !M PGF2! (p < .0001). The addition of
antimycin to this preparation of mitochondria reduced OCR to control levels.
Since both prostagandins and antimycin were dissolved in ethanol prior to to
addition to the media, influence of ethanol on succinate stimulated OCR was
determined and it was minor.
Clearly, the addition of PGF2! to these mitochondria was inhibitory and
reduced OCR, therefore reducing the production of ATP and perhaps the ability
to produce progesterone. Since both 1.0 µM and 10 µM PGF2! had similar
inhibitory effects on OCR, further experiments used 0.75 µM and 1.0 µM.
The influence of 0.75 µM and 1.0 µM PGF2! on OCR from mitochondria
isolated from bovine corpora lutea is depicted in Figure 4. Succinate stimulated
OCR was evident in both control treatments, averaging 82.9 ±11.5 nm. When
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PGF2! was added at 0.75 µM (p < 0.038) or 1.0 µM (p < 0.047) in the presence
of succinate, OCR was reduced more than 50%, averaging 46.0 ± 4.0 and 52.0 ±
8.9 nm respectively for 0.75 µM and 1.0 µM PGF2!. All molarities of PGF2!,
0.75 µM, 1.0 µM, and 10 µM (Figures 3 and 4) reduced OCR, indicating that
luteal cells exposed to PGF2! will not function properly. Luteolysis caused by
PGF2! may in part be associated with a direct effect of PGF2! on the luteal cell
mitochondria.
The influence of the addition of PGE2 to isolated mitochondria is depicted
in Figure 5. Succinate stimulated OCR was evident in both control treatments,
averaging 82.9 ± 11.8 nm of oxygen consumed per minute per mg of
mitochondria.

The addition of 30 µl of PGE2 (0.75 µM) in the presence of

succinate to a similar dispersion of mitochondria significantly (p < 0.021) inhibited
OCR levels, averaging 38.2 ± 10.2 nm. The addition of 30 µl of PGE2 (1.0 µM)
also significantly (p < 0.022) inhibited OCR levels, averaging 38.5 nm ±11.8 nm.
This was surprising, since PGE2 has been implicated as a stimulus of
progesterone production, which arises from mitochondrial activity. The positive
influence of PGE2 on luteal function cannot be explained by its negative effect on
the oxygen consumption of isolated mitochondria.
Prostaglandin Influence on Progesterone Secretion
The influence of PGF2! or PGE2 on progesterone production from
mitochondria isolated from bovine corpora lutea is shown in Figure 6.

22R-

Hydroxycholesterol, at a final concentration of 144 µM, was added as a precursor
for progesterone production. The amount of progesterone produced was low and
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similar across treatments, averaging 94.6 ± 18.7 ng. The addition of 22Rhydroxycholesterol had a minimal effect on progesterone production, averaging
93 ± 18.7 ng versus 86.2 ± 18.7 ng respectively for 0 and 144 µM 22Rhydroxycholesterol. In this unstimulated model of mitochondrial progesterone
production, the addition of PGF2! or PGE2 had only minor influences.
The influence of succinate, which stimulated OCR and electron movement
in the other experiments, is depicted in Figure 7. The addition of cholesterol and
succinate did not improve the amounts of progesterone produced, averaging
65.9 ± 10.6 ng/ml across all treatments, versus mitochondria alone which
averaged 84.5 ± 10.6 ng/ml. However, the addition of 30 µl of PGF2! (1 µM)
decreased progesterone synthesis compared to the control with succinate and
cholesterol, averaging 46.5 ± 10.6 ng/ml versus 58.1 ± 10.6 ng/ml respectively
for the 1 µM PGF2! versus 0 µM. Although succinate stimulated electron
movement in the respiratory electron transport chain, it was ineffective in
stimulating the synthesis of progesterone. The portion of the mitochondrial inner
membrane where steroidogenesis occurs was not stimulated by the addition of
succinate.

The inhibition of progesterone production by PGF2! might be

associated with its inhibition of oxygen consumption and adverse effect upon
ATP synthesis. If mitochondria are deprived of sufficient ATP, there exists the
possibility of a resulting decrease in progesterone production.
The low basal progesterone production obtained in the previous
experiments was unexpected, so the addition of NADPH, an electron donor
associated with cholesterol metabolism was added to stimulate progesterone
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production. The influence of the addition NADPH on progesterone synthesis is
depicted in Figure 8. When NADPH was added (1.0 mM) to the protocol, greater
amounts (p < .0001) of progesterone were produced compared to controls,
averaging 3100 ± 109.9 for 1.0 mM NADPH versus and 73.3 ± 109.9 for 0.0 mM
NADPH groups.
The influence of 30 µl of 0.75 µM or 1.0 µM PGE2 and PGF2! on NADPH
stimulated progesterone production is depicted in Figures 9, 1f0, 11, and 12.
NADPH stimulated large amounts of progesterone as seen in Figure 9, averaging
3448.0 ± 399.0 ng/ml of progesterone in the presence of 1.0 mM NADPH
compared to 236.4 ± 399.0 ng/ml of progesterone in the absence of NADPH.
The addition of 0.75 or 1.0 µM PGE2 (Figures 9 and 10) had minimal influence (p
< 0.7 or 0.9) respectively on progesterone production. The influence of 0.75 and
1.0 µM of PGF2! is illustrated in Figure 11. Clearly, as before, the addition of
NADPH stimulated (p < 0.0001) large amounts of progesterone. The addition of
1.0 µM PGF2! had minimal influence, whereas 0.75 µM reduced (p < 0.04)
progesterone production by 18%.
The standard error of the mean associated with NADPH stimulated
progesterone production was 399.0, which is 10% of the average progesterone
produced in the positive control treatment. Variances this large mask treatment
effects such as the 18% (600.0 ng/ml) drop in progesterone production in the
0.75 µM PGF2! treatment. To reduce the influence of this variance,
progesterone values were expressed as a fraction of the average control
progesterone production and are depicted in Figures 10 and 12. Nanograms of
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progesterone produced per ml for each treatment were divided by the average of
the positive controls and expressed as a fraction prior to statistical analysis.
In summary, the fraction of progesterone produced was reduced (p < 0.04)
by the addition of 0.75 µM PGF2! (Figure 12). The addition of PGF2! reduced
the fraction of progesterone produced by 28%. The addition of 1.0 µM PGF2! or
0.75 and 1.0 µM PGE2 did not significantly influence progesterone production
(Figures 10 and 12).
OCR Data
Crucial to an understanding of luteolysis is the study of those processes
which impinge upon the viability of the corpus luteum: cell respiration and
steroidogenesis.

Our in vitro studies on the effect of PGF2! and PGE2 on

respiration and steroidogenesis in bovine mitochondria have produced some
results which are similar and other results which differ from conclusions reached
in in vivo studies.
The decrease in oxygen consumption by PGF2! would be expected to
cause a subsequent decrease in ATP production. If the energy needs of the CL
are compromised, a loss of viability of luteal cells will ensue. What was
unanticipated about these results was the inhibition of respiration by PGE2
(Figure 5).
Since PGE2 is luteotropic, our results indicating inhibition of oxygen
consumption were surprising. However, there is support for inhibition of oxygen
consumption by PGE2 from other investigations. Lear et al., 1990, found that
exogenous PGE2 at a concentration of 30 µM inhibited transport-dependent
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oxygen consumption in the rabbit kidney by 70% and caused an increase in
cAMP by approximately 100%. Thus PGE2 may be interfering with the
phosphorylation of AMP to ATP. Rainsford (1980) found that PGE2 in a dose of
0.125 – 1.25 µg/ml inhibited oxygen consumption in rat gastric mucosal slices in
vitro, thereby reducing the capacity of the mucosa to produce ATP.
Both PGE2 (10 -6 g/kg/min) and PGF2! (10

-7

g/kg/min) decreased oxygen

consumption when infused into the carotids of anesthetized baboons, thus
providing evidence for the inhibitory effects on oxygen consumption of these two
prostaglandins in primates (Pickard et al., 1977).
Additional support for inhibition of oxygen consumption by PGE2 is
evident in a study of rat myocardial tissue (Noguchi et al., 2001).

Oxygen

consumption was reduced in cardiac muscle by the protein kinase C (PKC)
pathway.

Both PKC and PKA pathways are involved in the metabolism of

arachidonic acid.

Arachidonic acid has been shown to have a generalized

inhibitory effect on the sodium/potassium pump, The pump, also called the Na+ K+ - ATPase, maintains the gradients of these ions across the plasma membrane
via active transport against their concentration gradients. Therefore, interference
with the function of the pump results in a diminution of ATP. Investigations
indicate that inhibition of the pump is primarily due to PGE (Therien and Blostein,
2000). It is known that hypoxic conditions adversely affect the generation of
ATP. Although the exact mechanism by which PGE exerts its inhibitory effect
remains unknown, the possibility exists that a decrease in oxygen consumption
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caused by PGE may explain the multiple inhibitory effects of PGE2 through its
inhibition of electron transport and reduced ATP production.
At a molarity of 0.75 µM, inhibition of oxygen consumption by PGF2! is
significant at p < .0377 (Figure 4). This is approximately a 50% reduction. It is
evident that this inhibition reduces the amount of ATP available for luteal cell
activity and could contribute to the luteolytic effects of PGF2!.

A thorough

search of the literature has failed to disclose any prior investigations on the effect
of PGF2! on oxygen consumption.

However, it is commonly accepted that

PGF2! is the primary luteolysin. Since this study has indicated a significant
reduction in oxygen consumption by PGF2!, thus impacting ATP synthesis, our
results support a possible link between depletion of ATP and luteolysis.
Progesterone Data
Cholesterol alone is incapable of stimulating progesterone production in
this model system (Figure 6.) The addition of succinate (Figure 7) was also
ineffective in stimulating steroidogenesis. Succinate, although increasing oxygen
consumption, did not increase progesterone production. This may be the result
of a clear separation between electron movement in the ATP transport chain and
electron movement associated with progesterone synthesis. The cristae of the
mitochondrial inner membrane are not identical in arrangement in steroidproducing tissue and non-steroidal tissue.

The steroidal substructure of the

lamellar cristae contains a gap between membranes of approximately 4
nanometers. This is significant because the size of this gap is not sufficiently
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large to accommodate one of the subunits of ATP synthase (Prince and
Scheffler, 2002), thus precluding oxidative phosphorylation.
The addition of NADPH (Figure 8) provides the essential component for
successful steroidogenesis. The increase in progesterone production is highly
significant (p < .0001).

NADPH is required to stimulate the chain of events

which culminate in the synthesis of progesterone.

Stein and Tesone, 1992,

confirmed that the specific site of the action of NADPH is at the conversion of
cholesterol to pregnenolone within the mitochondria. The entrance of cholesterol
is also dependent upon the availability of oxygen and electrons, both of which are
contributed by NADPH (Sulimovici and Boyd, 1968). Thus NADPH is essential
for the process of steroidogenesis.
Many investigations have confirmed that PGF2! inhibits progesterone
secretion (Conley and Ford, 1989; Pate and Condon, 1989; (Gregoraszczuk and
Michas, 1999; Juengel et al., 2000; Fitz et al., 1993). There is a common
consensus that PGF2! decreases progesterone in intact animals (Fitz et al.,
1993; Girsh et al., 1996a; McCracken et al., 1972; Niswender and Nett, 1994).
PGF2! decreases progesterone from purified preparations of ovine and bovine
large luteal cells (Wiltbank et al., 1991). In vivo, very low levels of PGF2! (" 250
pg/ml) are required to depress progesterone secretion in sheep (McCracken,
1999). The evidence that PGF2! has an inhibitory effect is substantial. When
PGF2! was added to the mitochondria, progesterone production was inhibited
even in the presence of NADPH. PGF2! inhibited both baseline (Figure 7) and
NADPH-stimulated progesterone production (Figure 11). PGF2! clearly inhibited
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the movement of electrons in the ATP transport chain (Figure 4), which might
have contributed to the inhibition of baseline progesterone production. In the
presence of NADPH, which stimulated a 10-fold increase in progesterone
production, PGF2! reduced progesterone production by 28%, indicating that
PGF2! was influencing the movement of electrons along the steroidogenic
transport chain.
PGF2! decreases the synthesis of progesterone via multiple mechanisms.
It is speculated that progesterone could be decreased by several intracellular
events, including down-regulation of receptors, decreased uptake of cholesterol,
decreased transport of cholesterol across mitochondrial membranes, and
decreased activity of the enzymes required for the synthesis of progesterone.
These anti-steroidogenic effects of PGF2! appear to be mediated by the protein
kinase C secondary messenger pathway (Niswender et al., 2000). When PGF2!
binds to receptors on the large luteal cells, a chain of events is set in motion
which ultimately results in an increase in calcium (Juengel et al., 1996;
(Abramovitz et al., 1994; Graves et al., 1995). Calcium promotes the synthesis
of additional PKC and inhibits synthesis of cholesterol (Niswender et al., 2000;
(McGuire et al., 1994; Boujrad and Hudson, 1993). The decrease in cholesterol
may be another of the mechanisms whereby PGF2! inhibits the synthesis of
progesterone. Confusion results from recent reports that both PGE2 and PGF2!
at concentrations of 1µM stimulate progesterone synthesis in bovine luteal cells
in vitro when incubated for 24 hours (Bowolaksono et al., 2008). This result is in
contrast with our results in Figure 7 and Figure 10. Also surprising was the
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conclusion of Bowolaksono et al., that PGE2 and PGF2! exert luteoprotective
roles by suppressing apoptosis in the large luteal cells.
In vitro, PGF2! prevents cholesterol from interacting with the side-chain
enzyme (P450scc), resulting in an initial drop in progesterone in incubated whole
luteal cells (Grusenmeyer and Pate, 1992). After this initial drop in progesterone,
StAR mRNA declines, compounding the loss of progesterone (Pescador et al.,
1996). The decrease in StAR suppresses the availability of cholesterol, since
StAR is required for the transfer of cholesterol to the tubular sites of the
mitochondria where much of the P450scc is located (Jefcoate and Artemenko,
2004). The decrease in StAR mRNA occurs after the initial drop in progesterone,
and therefore, fails to explain the initial drop in progesterone synthesis. Attempts
to locate the precise site within the luteal cell where PGF! exerts its effects
continue to be illusive (Pate, 2012).

However, in the present study, PGF2!

directly influenced the mitochondria in some manner such that less progesterone
was produced.
Membrane Permeability and Prostaglandins
How do prostaglandins diffuse into a luteal cell and influence
mitochondria? Because of their lipid nature, prostaglandins were originally
thought to traverse cell membranes by passive diffusion. Although PGE2 and
PGF2! are able to pass through membranes by diffusion, diffusion is too slow to
be suitable for cellular needs. Since prostaglandins are orgainic anions, they
traverse membranes inefficiently. This is the result of the nature of both the
plasma membrane and the mitochondrial membrane, which both consist of a
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bilayer of phospholipids. The hydrophilic heads of the phospholipids are exposed
to the aqueous milieu outside the mitochondrion and the hydrophobic tails
inside the membrane, apposed to the inner membrane, where the phospholipids
are similarly arranged. The externally oriented phosphate heads are negatively
charged, as are the prostaglandins.

The positioning of these two negative

charges impedes entrance of negatively charged substances such as
prostaglandins.
Prostaglandins typically enter membranes with the aid of receptors and
transporters. The mitochondria in our investigation are intact, and therefore the
mitochondrial membrane would possess receptors. Carrier-mediated transport
enables prostaglandins to cross cell membranes faster than diffusion (Schuster,
2002). Bovine prostaglandin transporter (PGT) assists the entrance and exit of
both PGE2 and PGF2! with equal affinity. PGT is involved in transport within the
bovine uterus and from the uterus to the uterine-ovarian plexus, where the
prostaglandins primarily affect the large luteal cells (Arosh 2004).

When

transported to the luteal cell by PGT, both PGE2 and PGF2! enter the cell via G
protein-coupled receptors. In the bovine these are primarily PGE2 receptors EP2
and EP4 and PGF2! receptor FP, which are located on the luteal cell membrane.
Unfortunately, there is a lack of information regarding the structure of the EP2
and EP4 receptors (Regan, 2003).
Prostaglandins may either bind to luteal cells to exert their effects or be
synthesized within luteal cells.

However, their influence upon mitochondrial

function is dependent upon second messengers, since PGE2 and PGF2! are
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excluded from the inner mitochondrial membrane. The outer mitochondrial
membrane (OMM) contains integral proteins called “porins”.

Porins form

channels 2-3 nm in diameter, which permit molecules of 5000 Daltons or less to
freely diffuse across the membrane (Alberts et al.1994).

Since the inner

mitochondrial membrane is devoid of porins, ions and molecules require
transporters (Alberts et al., 1994).

These transporter proteins allow the

membrane to be selectively permeable to small molecules such as ATP.
Mitochondria and Luteolysis
Crucial to an understanding of luteolysis is the study of those processes
which impinge upon the viability of the corpus luteum: cell respiration and
steroidogenesis.
Mitochondria control the corpus luteum in three ways.

They generate

most of the ATP required by the cell for energy. They are the site of the initial
stage of steroidogenesis during which pregnenolone is metabolized to
progesterone. They release pro-apoptotic proteins that activate a cascade which
culminates in regression of the CL.
The thousands of mitochondria in the average cell generate most of the
ATP required by the cell for energy. Deprived of oxygen, cellular respiration will
cease and the amount of ATP available to the cell will diminish, since oxygen
functions as the terminal electron acceptor in the process of oxidative
phosphorylation. Low oxygen affects not only the energy needs of the cell, but
adversely affects cultured bovine luteal cells. The processes of cellular
respiration and steroidogenesis are allied and therefore, these processes are not
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distinct from each other.

Whatever affects oxygen consumption will affect

steroidogenesis. In support of this contention is the finding that mitochondria in
Leydig cells must be actively respiring to support steroidogenesis (Allen et al.,
2006). Pregnenolone, the precursor of progesterone, is inhibited in low oxygen
conditions, resulting in functional luteolysis (Nishimura et al., 2006).

Both of

these processes occur on the mitochondrial inner membrane, although in
separate regions.
Structural luteolysis of the CL occurs when the mitochondria release
apoptotic proteins, such as cytochrome c. If apoptosis occurs at the appropriate
time in the ovarian cycle, it is beneficial, causing regression of the CL and the
initiation of a new cycle.

Luteolysis in ruminants is initiated by the binding of

PGF2! to its FP receptor on the luteal membrane. As a result, free calcium is
released and protein kinase C is activated (PKC). Subsequent events await
further investigation, but could include PGF2! transport to the mitochondria, a
decrease in steroidogenic enzymes and a loss of structural integrity of the CL
(Diaz et al., 2000).
The collective results from our experiments verify the luteolytic effects of
PGF2!. For the first time, this study has documented the detrimental effects on
cell respiration of PGF2!, which doubtless contributes to the inhibition of
steroidogenesis. Our determination of the effect of PGF2! on cellular respiration
in luteal mitochondria represents new data. To our knowledge, this study is the
first to investigate the effect of PGF2! on mitochondrial oxygen consumption in
ruminants.
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The mechanism of the role of PGF2! within the corpus luteum remains a
conundrum (Pate, 2012). However, the pieces of the puzzle are beginning to
come together. The dual processes of cellular respiration and steroidogenesis
both occur on the inner mitochondrial membrane. Future studies need to be
designed to elucidate how both electron transport mechanisms are positioned on
the membrane and how both PGE2 and PGF2! influence them.
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Figure 1. Equation for determination of oxygen consumption rate.
The Clark electrode communicates with a computer to produce a trace
similar to the one pictured above. Analysis of the graphs generated in our
respiration trials permitted determination of the amount of oxygen consumed.
Measurements between the points indicated on the graph were factored into the
equation shown.
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Figure 2. Effect of succinate (20 mM) and antimycin (0.02 mM) on oxygen
consumption rate in mitochondria (1.5 mg/ml) isolated from bovine luteal cells.
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Figure 3. Effect of various concentrations of PGF2! (0, 0.01, 1.0, or 10 µM) on
oxygen consumption in mitochondria (1.5 mg/ml) isolated from bovine luteal cells
with succinate (20 mM), ethanol (0 µl added to 0 PGF2!, .4 µl added to 0.01 µM
PGF2!, 40 µl added to 1 µM PGF2!, 400 µl added to 10 µM PGF2!), antimycin
(0.02 mM) was added as indicated.
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Figure 4. Effect of PGF2! (0.75 and 1.0 µM) on oxygen consumption in
mitochondria (1.5 mg/ml) isolated from bovine luteal cells with ethanol (30 – 40
µl), succinate (20 mM) at 37° C. Control 1 = 30 µl ethanol, mitochondria,
succinate (20 mM). Control 2 = 40 µl ethanol, mitochondria, succinate (20 mM).
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Figure 5. Effect of PGE2 (0.75 and 1 µM) on oxygen consumption in
mitochondria (1.5 mg/ml) isolated from bovine luteal cells with ethanol (30-40 µl)
and with succinate (20 mM). Control 1 = 30 µl ethanol, mitochondria, succinate
(20 mM). Control 2 = 40 µl ethanol, mitochondria, succinate (20 mM).
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Figure 6. Effect of PGE2 and PGF2! (0.75 and 1 µM) on synthesis of
progesterone from mitochondria (1.5 mg/ml) isolated from bovine luteal cells with
or without cholesterol (144 µM), and ethanol (6-7 µl).
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Figure 7. Effect of PGE2 AND PGF2 ! (0.75, 1 µM) on synthesis of
progesterone from mitochondria (1.5 mg/ml) isolated from bovine luteal cells with
or without cholesterol (144 µM), succinate (20 mM), ethanol (6-7 µl) at 37°C.

Figure 7. Effect of PGE2 AND PGF2 ! (0.75 and 1 µM) on synthesis of
progesterone from mitochondria (1.5 mg/ml) isolated from bovine luteal cells with
or without cholesterol (144 µM), succinate (20 mM), and ethanol (6-7 µl).
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Figure 8. Effect of the addition of NADPH (1mM) on synthesis of progesterone
in mitochondria (1.5 mg/ml) isolated from bovine luteal cells with cholesterol (144
µM), succinate (20 mM) and NADPH (1 mM).
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Figure 9. Effect of PGE2 (0.75 and 1 µM), antimycin (0.02 mM), cholesterol
(144 µM), ethanol (6-7 µl), and NADPH (1 mM) on progesterone synthesis in
mitochondria isolated from bovine luteal cells at 37° C. Negative control =
mitochondria, and ethanol; positive control = mitochondria, cholesterol, and
NADPH expressed as ng/mL.
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Figure 10. Effect of PGE2 (0.75 and1 µM), antimycin (0.02 mM), cholesterol
(144 µM), ethanol (6-7 µl), and NADPH (1 mM) on progesterone synthesis in
mitochondria isolated from bovine luteal cells at 37° C. Negative control =
mitochondria, and ethanol; positive control = mitochondria, cholesterol, NADPH
expressed as relative value.
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Figure 11. Effect of PGF2! (0.75 and 1 µM) on progesterone synthesis in
mitochondria (1.5 mg/ml) isolated from bovine luteal cells with ethanol (6-7 µl),
cholesterol (144 µM), NADPH (1 mM), antimycin (0.02 mM) at 37°C. Negative
control = mitochondria, and ethanol; postive control = mitochondria, cholesterol,
and NADPH expressed as ng/mL.
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Figure 12. Effect of PGF2! (0.75 and 1 µM) on progesterone synthesis in
mitochondria (1.5 mg/ml) isolated from bovine luteal cells with ethanol (6-7 µl),
cholesterol (144 µM), NADPH (1 mM), antimycin (0.02 mM) at 37°C. Negative
control = mitochondria, and ethanol; positive control = mitochondria, cholesterol,
NADPH expressed as relative value.
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